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1       Introduction 
Coccidiosis in poultry is caused by infection with Eimeria spp. This disease has great economic 
impact on poultry production particularly in intensively reared herds (WALLACH et al. 1995; 
WILLIAMS 1998; 1999; LILLEHOJ and LILLEHOJ 2000). 
Different attempts have been made to immunize chicken against coccidiosis throughout the 
world by using low doses of sporulated oocysts (EDGAR 1958), irradiated sporulated oocysts 
(REHMAN 1971), sporozoites (GARG et al. 1999), merozoites, recombinant merozoite antigen 
(JENKINS 1998) recombinant refractile body antigen (KOPKO et al. 2000) and inactivated 
sporulated oocysts (AKHTAR et al. 2001). None of these experimental vaccines reached to 
commercial scale. In the late 80’s and early 90’s, vaccines based on virulent or attenuated status 
(LEE 1987; SHIRLEY 1989; BEDRNIK 1996) were developed and are being marketed now in 
different countries. 
Some antibodies with inhibitory effect on various Eimeria - stages have been identified 
(DANFORTH et al. 1985; LILLEHOJ and CHOI 1998; LABBE et al. 2005). Antibodies 
produced in plants used for animal feeding could offer a simple and cheap biopharmaceutical 
application to protect exposed herds. 
The present study was conducted to investigate the effect of some antibody fragments against 
Eimeria tenella which have been molecularly expressed in a transgenic pea plant. Both in vitro 
and in vivo infection experiments were used to evaluate the inhibitory effect of these antibodies 
on E. tenella by indirect immunofluorescence, antibody neutralization test and flow cytometry. 
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2       Literature review 
2.1  Taxonomy 
Coccidiosis, is an intestinal disease of intensively reared livestock and is caused by protozoa 
belonging to the taxonomic family Eimeridae and the phylum Alveolata (SCHNIEDER and 
TENTER 2006). Most commonly recognized coccidia infecting chickens and other poultry are of 
the genus Eimeria (MCDOUGALD 2008). The genus Eimeria is classified according to 
SCHNIEDER and TENTER (2006) as follows: 
Kingdom Protozoa, 
 Phylum Alveolata, 
  Subphylum Apicomplexa, 
   Class Coccidia, 
    Subclass Coccidiasina, 
     Order Eimeriida, 
      Family Eimeriidae, 
       Genus Eimeria 
Coccidiosis has an economical significant incidence and even subclinical coccidiosis causes 
impaired feed conversion. Eimeria spp. are obligate intracellular parasites of the intestinal tract, 
but some species have been found in other organs such as the kidney and liver. 
Most Eimeria spp. are highly host specific with a direct life cycle and infect only one host 
species or a range of closely related host species. Multiple distinct Eimeria spp. infecting the 
same host develop in species specific sites (Table 1). There are currently seven recognized 
species of Eimeria infecting chickens, including E. acervulina, E. brunetti, E. maxima, E. mitis, 
E. necatrix, E. praecox and E. tenella. Mixed infections with two or more of these species are 
more common than monospecific infections (REID and LONG 1979). 
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Table 1: Eimeria species of the domestic fowl, Gallus gallus (REID and LONG 1979) 
Species Region infected Location in tissue Prepatent 
period 
Average oocyst 
size (L x W, µm) 
E. acervulina Duodenum Epithelial 97 18.3 x 14.6 
E. brunetti Lower intestine, 
rectum 
Subepithelial (second 
generation meronts) 
120 24.6 x 18.8 
E. maxima Upper intestine, 
ileum 
Subepithelial 
gametocytes 
121 30.5 x 20.7 
E. mitis Upper intestine Epithelial 99 16.2 x 16.0 
E. praecox duodenum, upper 
jejunum and mid-
intestine 
Epithelial 83 21.3 x 17.1 
E. necatrix Cecae Subepithelial (second 
generation meronts) 
138 20.4 x 17.2 
E. tenella Cecae Subepithelial (second 
generation meronts) 
115 22.0 x 19.0 
 
2.2  Life cycle 
The infection with Eimeria species is initiated when the sporulated oocyst is ingested by a 
suitable host; sporocysts are released into the intestinal lumen (Figure 1). They excyst with the 
aid of a variety of factors including mechanical disruption of the oocyst wall, enzymatic 
digestion with trypsin, and the presence of bile salts and carbon dioxide.  
The released sporozoites then penetrate epithelial cells of the intestinal villi where they either 
develop directly within enterocytes or are transported, by host cells, to a specific location where 
they develop into trophozoites and then meronts to initiate merogony (LILLEHOJ and TROUT 
1996). Following invasion of villar epithelial cells, sporozoites of E. maxima and E. tenella are 
transported from the epithelium to the lamina propria and finally to the crypt epithelium where 
development continues.  
Merozoite formation occurs through asexual schizogony (multiple simultaneous cellular fission) 
with subsequent release of merozoites that invade other cells, and initiate another merogonic 
cycle. The number of merogonic cycles is genetically determined and different for each species 
or strain (precocious parasites often lack one or more merogonic replicative cycles).  
Merozoites from the final generation invade intestinal cells to develop into macro- and 
microgamonts through gametogony. Each macrogamont matures into one large macrogamete; 
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the microgamonts divide to form many flagellated microgametes. The microgametes penetrate 
and fertilize a macrogamete to form the zygote, an unsporulated oocyst. The unsporulated oocyst 
breaks out of the host cell or is sloughed with its host cell and passed in the faeces (ROSE 1987).  
In the absence of reinfection the parasites are cleared from the host in 7 to 14 days depending on 
the species, irrespective of the host response to the parasites. Thus, the life cycle of the parasite 
in an infected host is self-limiting.  
Sporulation occurs outside of the host in the presence of oxygen. The unsporulated oocyst 
develops to form four sporocysts, each of which differentiates to contain two mature sporozoites. 
The environmentally resistant sporulated oocyst is the infective stage of the parasite. 
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Figure 1: Life cycle of Eimeria. Following the ingestion of a sporulated oocyst (a) sporozoites 
are released from sporocysts (b) and sporozoites invade villar epithelial cells (c). Merozoites are 
formed through merogony (d) and are released to invade new cells and initiate subsequent 
rounds of merogony (e). Final generation merozoites invade new cells to initial sexual 
development, or gamogony (f) whereby microgamonts (g) and macrogamonts (h) are formed. 
Microgamonts develop into microgametes that are released to fertilize the single macrogamete 
that has developed from the macrogamont (i) to form the zygote, which moves out of the host 
with the feces as (j) unsporulated oocyst. The unsporulated oocyst develops into the infective, 
sporulated oocyst following exogenous sporulation (j-l). copyright for (MCDOUGALD 2008) 
2.3  Host-parasite relationship 
Recently particular attention has been paid in diverse Eimeria species to organelles involved in 
the invasion of the host cells by extracellular motile stages of Eimeria located within the apical 
complex (DANFORTH et al. 1989). Increasing resistance of avian coccidiosis against selective 
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drugs has stimulated the search for novel and alternative methods of control such as vaccines 
(MCDOUGALD 2008). This requires specific coccidial antigens to be recognized and 
characterized. Certain regions on the cell surface of the coccidial parasite have been shown to 
possess discrete immunogenic properties (DANFORTH and AUGUSTINE 1989). 
2.4  Invasion of host cells 
Invasive stages (zoites) of all Apicomplexa, including Eimeria spp., possess an apical complex. 
This apical complex, consisting of the polar ring, conoid, rhoptries, micronemes and dense 
granules, is used to penetrate host cells (CARRUTHERS and SIBLEY 1997). Apicomplexan 
parasites actively invade specific host cells in a process in which the host cell plays no active 
role (SIBLEY et al. 1998). Following the initial recognition between a zoite and host cell, 
penetration into the host cell is initiated by contact between the zoite apical region and the 
surface of the host cell. The zoite moves progressively into the developing parasitophorous 
vacuole (PV), which forms as the parasite enters the cell and is contiguous with the host cell 
plasmalemma. Several organelles of the apical complex, the micronemes, rhoptries and dense 
granules, are important to host cell invasion, during which the contents of these organelles are 
sequentially released. The invasive process, driven by the parasite, depends on the gliding 
motility of the zoite, which is dependent on actin and myosin (RUSSELL 1983; AUGUSTINE 
2001). 
The invasion of specific cells by Eimeria spp. zoites suggests the presence of specific surface 
membrane sites mediating contact and cell entry (LILLEHOJ and TROUT 1996). Host-cell 
selection by parasites must allow for optimal survival and development of the parasites. 
Protozoan sporozoites have D-galactose residues on their surfaces; host cells have receptors that 
recognize these carbohydrates. Interaction between these moieties may occur prior to cell 
penetration (BABA et al. 1996). Merozoites and microgametes of E. tenella express a 
fibronectin-like molecule that may mediate host cell recognition and penetration. An integrin 
receptor, demonstrated on merozoites, may also be involved in the parasite-host cell interaction 
(LOPEZBERNAD et al. 1996). 
Following invasion, several changes occur in the host cell. For example, after invasion of host 
cells by merozoites of E. necatrix there was an increase in cell volume leading to increased 
surface area due to the formation of a new membrane. The infected cells became invasive, 
leaving the crypt and entering the lamina propria and muscle tissue. This process was assisted by 
tissue breakdown by secreted collagenase. Accumulation of mitochondria around the PV was 
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noted as well as formation of intravacuolar tubules and hypertrophy of the nucleus. The infection 
led to alterations in the host cell membrane that led to increased susceptibility to trypsin and, 
ultimately, cell lysis. Lysis of the host cell allows for merozoite release without a unique 
mechanism suggesting that the morphological changes of the host cell may be tied to the 
parasite's life cycle (PASTERNAK and FERNANDO 1984; AUGUSTINE 2001; 
CARRUTHERS and TOMLEY 2008). 
2.5  Effects of Disease 
Infection of the gastrointestinal tract by Eimeria spp. results in an alteration of the mucosa that 
may give rise to enteric disease. Signs of disease include anorexia, weight loss, huddling, 
ruffling of feathers, soft stools and death. At necropsy, intestinal lesions are visible that, along 
with history and scrapings of intestinal mucosa, can be used to diagnose the disease 
(MCDOUGALD 2008). The intestinal mucosa is damaged directly by the parasites and 
indirectly through the host's inflammatory responses to the parasites. The damage is manifested 
both structurally and physiologically as mucosal hypertrophy, villous atrophy, increased vascular 
permeability, and epithelial and vascular damage. Villous atrophy is related to several 
mechanisms. Exfoliation of villar cells into the lumen and exposure of lamina propria stromal 
cells at the villar tip occur following infection of surface enterocytes, leading to atrophy and 
damage to the proliferative cells in the crypt decreasing the ability for epithelial renewal. Cell 
mediated immune responses (CMI) by the host also affect mucosal integrity. Inflammation, 
haemorrhage and necrosis can be induced by lymphoid effector cells in the mucosa and 
submucosa, with changes in vascular permeability leading to oedema and haemorrhage 
(BARKER 1993). 
2.6  Severity of Disease 
The severity of avian coccidiosis is affected by external and internal factors. Environmental 
factors, as well as diet, management and stress all affect the severity of disease. The amount and 
types of nutrients in the diet are important, as for example, birds fed on low protein diets develop 
less severe disease. Commercial poultry houses that are maintained with high temperatures and 
humidity generally have flocks with less severe disease (RUFF 1993). 
Genetics, age, disease interactions, nutritional state and immunity are internal factors which may 
affect the severity of disease (RUFF 1993). Susceptibility to disease is affected by the host 
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genome. Breeds and individuals within breeds differ in susceptibly to coccidiosis (JEFFERS 
1978). These differences in susceptibility may arise due to random genetic differences between 
strains. For instance, FP strain chickens are more susceptible than are SC strain chickens to 
disease due to infections with E. maxima, E. acervulina and E. tenella (LILLEHOJ and RUFF 
1987) Concurrent diseases and infections, such as Marek's disease and infectious bursal disease, 
may increase the severity of coccidiosis. Development of specific immunity following primary 
infection may greatly reduce the severity of disease after subsequent infections. 
2.6  Immune response to Eimeria spp. infecting chickens 
The complex life cycle of Eimeria species consists of intracellular, extracellular, asexual and 
sexual developmental stages resulting in a complex host immune response. This necessitates a 
better understanding of host-parasite interactions and of protective immune mechanisms for 
successful prevention and control practices (DALLOUL and LILLEHOJ 2005). The 
development of immunity is strongly influenced by many factors including the species of 
Eimeria infecting the chicken, the stage responsible for intestinal damage, the number of oocysts 
ingested, host age, genotype, general health, and on whether a primary or secondary response is 
occurring (LILLEHOJ and TROUT 1996; SWINKELS et al. 2006). 
The immune responses elicited to Eimeria spp. can be categorized into non-specific and specific 
immunity as reviewed by (DALLOUL and LILLEHOJ 2005); where the specific immunity is 
composed of cellular and humoral immune response mechanisms. The non-specific immune 
responses include physical barriers, phagocytes and leukocytes, and complement whereas the 
specific one is mediated by antibodies, lymphocytes and cytokines. 
Host defence mechanisms are activated following sporozoites invasion of host cells inducing 
local inflammatory reaction. Increased intestinal permeability results in plasma leakage from the 
vasculature and is coincident with cell invasion (CASTRO 1989). Following sporozoite invasion, 
leukocytes and other components of the gut-associated lymphoid tissue (GALT) are found at the 
site of infection, including macrophages, B-lymphocytes, T-lymphocytes and soluble factors 
(mucin, enzymes, antimicrobial peptides, immunoglobulins and cytokines) (LILLEHOJ 1998) 
Activated macrophages modulate the severity of infection and reduce numbers of sporozoites 
and merozoites through phagocytosis (LEE and AL-IZZI 1981). CD4+ T-cells help to induce 
antibody and cell mediated immunity after the primary infection. The marked increase of CD4+ 
cells suggests that these cells are involved in the induction of the immune response and of 
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antibody production, whereas the increase of CD8+ cells after challenge infection suggests that 
these cells act as effector cells and are involved in cell mediated immunity (VERVELDE et al. 
1996). 
Immunity affects early stages of the parasite likely through limiting invasion, inhibition of 
sporozoite and merozoite development and induces parasite death followed by removal with host 
cells, resulting in parasite elimination (JEURISSEN et al. 1996) 
2.7  Role of Gut-associated lymphoid tissues (GALT) and mucosal-associated 
lymphoid tissue (MALT) 
In general the GALT serve three functions in host defence against Eimeria spp. infections: 
processing and presentation of antigens, production of intestinal antibodies (primarily secretory 
IgA), and activation of cell mediated immunity (CMI) (YUN et al. 2000b; DALLOUL and 
LILLEHOJ 2005). In chickens the GALT include the bursa of Fabricius, cecal tonsils, Payer’s 
patches, and lymphocyte aggregates in the intraepithelium and in the lamina propria of the 
intestinal wall of the gastrointestinal tract (LILLEHOJ and TROUT 1996). In the immune hosts, 
parasites enter the gut early after infection but are prevented from further development, 
indicating that acquired immunity to coccidiosis may involve mechanisms that inhibit the natural 
progression of parasite development (LILLEHOJ and TROUT 1996). 
Intestinal lymphocyte populations following infection with Eimeria spp. have been extensively 
investigated by several research groups (LILLEHOJ and BACON 1991; OVINGTON et al. 
1995; BESSAY et al. 1996). Increased numbers of duodenal CD4+ lELs from 4 days through 14 
days post-infection result from E. acervulina (BESSAY et al. 1996). Also there were fewer 
increases in CD8+ and γδ-TCR+ cells at 12th days post-infection and numbers decreased by the 
p.i. day 14. Following secondary infection with E. acervulina, CD8+ T-cells increased 
(LILLEHOJ and BACON 1991). The authors speculated that CD8+ T-cells and natural killer 
(NK) cells were involved in protective immunity due to significant increases in these cells at the 
site of infection in naive and immunized breeds of chickens. 
The most important role of mucosal-associated lymphoid tissue (MALT) is to destroy invading 
pathogens at their port of entry to prevent dissemination and systemic infection throughout the 
host. This function is accomplished in a number of different ways including non-specific barriers 
such as gastric secretions, lysozymes and bile salts, peristalsis, and competition by native 
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microbial flora that provide an important component of the first line of defence in the MALT 
(SANDERSON and HE 1994). 
Following the primary infection with E. tenella, an infiltration of the mucosa by T-cells, 
predominantly CD4+ and also CD8+ cells, and macrophages was observed in chickens 24 to 96 
hours post-infection. The CD4+ cells were thought to be involved in the induction of a cytotoxic 
response, MHC Class II recognition and the production of cytokines. In immune challenged 
chickens, lymphocyte migration to the intestine was more rapid and involved mostly CD8+ cells 
surrounding sporozoites in the lamina propria. More cells were observed in the lamina propria of 
these birds than in naive birds, mostly representing CD4+ and less frequently CD8+ 
(VERVELDE et al. 1996). 
Increases in CD8+ cells but not γδ-TCR+ cells were observed following primary infection with 
E. tenella. CD4+ cells increased 8 days post-infection and decreased by 14 days (BESSAY et al. 
1996). The authors, in comparing the response to E. tenella with that to E. acervulina, concluded 
that there might be differences in the early immune infection response of chicken to eimerian 
parasites based on the sites of development (cecum vs. duodenum). It appeared that the number 
of CD8+ lymphocytes was relatively more elevated in distal regions of the intestinal tract. One 
hour following primary infection with E. maxima, local lymphocytes initially decreased and then 
increased 3 to 7 hours later. Most of the responding lymphocytes were T-cells rather than B-
cells. Subsequent T-cell responses were biphasic, with increases in the number of CD4+ cells in 
the lamina propria observed on day 3 and day 11 following primary infection. Little response 
was observed in epithelial CD4+ cells. Following challenge infection, increases were observed in 
lamina propria CD4+ cells at 0.5 and 3 hours. The CD8+ populations infiltrated the lamina 
propria and intraepithelial regions, similar to CD4+ cells. The numbers also increased following 
challenge, most notably in the epithelium. Greater numbers of γδ-TCR+ cells were observed in 
the epithelium than in the lamina propria. This population peaked on day 11 post-infection. αβ-
TCR+ cells were observed in both regions but in greater numbers in the lamina propria 
(ROTHWELL et al. 1995). 
2.8  Antibody Responses to Eimeria spp. 
The definitive role of humoral immunity against poultry coccidiosis is still unclear. Similar to 
mammals, three classes of antibodies are recognized in birds, viz immunoglobin IgM, IgA, and 
IgY. Each antibody class has at least one monomer of heavy chains and of light chains. Both 
heavy and light chains have a variable domain at the N-terminal position and 3 or 4 constant 
Literature review 
11 
domains at the C-terminal region. Depending on the types of constant regions of the heavy (H) 
chains, the antibodies are classified into IgM (µH chain), IgA (αH chain), and IgY (γH chain) 
(LILLEHOJ et al. 2004). IgY is considered orthologue to the mammalian IgG (LESLIE and 
CLEM 1969). 
Maternal IgY is concentrated in the yolk sac of the egg (ROSE et al. 1974) and its transportation 
to the chicken embryo during late development was found to be similar to that found in 
mammals (WEST et al. 2004). Thus it is regarded as a carrier for the maternal passive immunity 
(LILLEHOJ et al. 2004). Passive antibodies, transferred to chicks by hens immunized by 
gametocyte surface antigens of E. maxima, reduced oocyst output in those birds after challenge 
with sporulated E. maxima oocysts. Maternal antibodies induced by infection with E. maxima are 
able to partially protect hatchlings against infection with E. tenella (WALLACH et al. 1992) and 
the E. tenella egg-propagated gametocyte vaccine induced protective immunity against E. tenella 
infections in offspring chicken (ALLEN et al. 1997; ANWAR et al. 2008). 
Increased production of IgA, IgM and IgY following infection with an upper intestinal species 
(E. acervulina) and with a cecal species (E. tenella) was observed in the serum and locally at the 
site of infection in the intestinal secretions. Following infection with E. acervulina significant 
increases in secretory IgA (sIgA) were observed in mucosal tissue from the duodenum and 
cecum 14 days post-infection (GIRARD et al. 1997). However, antibody responses have a minor 
role in protective immunity to Eimeria spp. because agammaglobulinemic chickens produced by 
hormonal and chemical bursectomy are though resistant to reinfection with Eimeria spp. (ROSE 
and LONG 1970; YUN et al. 2000a). 
The role of sIgA during infections is not clearly understood but is believed to be minor. Chickens 
lacking the isotype are still resistant to infection (LILLEHOJ 1993). Its main role may be in the 
prevention or reduction of invasion of some (but not all) species of Eimeria or it may enhance 
the intraluminal destruction of sporozoites if parasites come into close contact with local 
antibodies before the parasites enter host cells (LILLEHOJ 1993). Moreover, it possibly inhibits 
sporozoite and merozoite development (LONG et al. 1982). IgA may attach to the coccidial 
surface and prevent binding to the epithelium by direct blocking, steric hindrance, and induction 
of conformational changes and/or reduction of motility (XUAMANO et al. 1992). 
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2.9  Cell-Mediated immune (CMI) responses to Eimeria 
It has been reported that cell mediated immunity plays a major role in resistance to coccidiosis 
by developing a protective immune response involving T-lymphocytes, macrophages and natural 
killer (NK) cells (LILLEHOJ et al. 2004). Antigen-specific T cell responses against Eimeria spp. 
have been demonstrated in chickens using in vitro lymphocyte proliferation assays. T-
lymphocytes isolated from chickens infected with E. tenella proliferated when stimulated with 
soluble antigen from developmental stages of E. tenella (ROSE and HESKETH 1984). This 
proliferative response did not occur when the Eimeria spp. from which the soluble antigen was 
obtained differed from that used to infect the chicken whose lymphocytes were under evaluation 
(LILLEHOJ 1986). 
2.9.1  T-lymphocytes 
The importance of T-lymphocytes in mediating resistance has been shown partly through 
transfer and depletion experiments. It is possible to adoptively transfer immunity to Eimeria spp. 
with T-cells from immune birds (OVINGTON et al. 1995). Induction of immunosuppression by 
administration of cyclosporin before the primary inoculation of Eimeria species increased 
susceptibility and administration of cyclosporin prior to secondary inoculation eliminated 
protective immunity (TROUT and LILLEHOJ 1996). Depletion of CD4+ cells had no effect on 
the development of immunity. However, following depletion of CD8+ cells, resistance to 
secondary infection was cancelled. The authors concluded that the role of CD4+ cells was during 
primary immune responses possibly in the production of interferon (IFN) and the role of CD8+ 
cells was that of effectors against infected epithelial cells. 
2.9.2  Macrophages  
Macrophages reduced infection with E. tenella and disease severity (QURESHI et al. 2000). 
Macrophages are antigen presenting cells and mediate immune responses to the parasites. 
Through the secretion of cytokines, macrophages modulate responses by other cells of the 
immune system and by epithelial cells. They also function as effector cells through the 
production of tumour necrosis factor (TNF), reactive oxygen intermediates (ROI) and reactive 
nitrogen intermediates (RNI), all of which have anti-parasitic effects (VERVELDE et al. 1996) 
and are increased during infections with Eimeria spp. (QURESHI et al. 2000). This is 
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accompanied by changes in CD4+ and CD8+ T-cell subpopulations (CORNELISSEN et al. 
2009). 
2.9.3  Natural killer (NK) cells 
NK cells are non-T, non-B, and non-macrophage mononuclear cells with characteristic 
morphology that are capable of spontaneous cytotoxicity against a wide variety of target cells. 
Because NK cells lack immunological memory and MHC restriction, their cellular lineage is 
debatable (LILLEHOJ 1993). 
NK cell activity has been demonstrated in the spleen (ROSE et al. 1979; LILLEHOJ 1989), 
peripheral blood (LEIBOLD et al. 1980), thymus, bursa, and intestine (CHAI and LILLEHOJ 
1988; LILLEHOJ and CHAI 1988). These cells are found in greatest quantity in the 
intraepithelial compartments in the early stages of coccidial infection (ROSE et al. 1979; 
LILLEHOJ 1989) suggesting that their role may be to control parasite proliferation. 
2.9.4  Blood leukocytes  
Blood leukocytes, including polymorphonuclear (PMN) cells, large mononuclear (LMN) cells 
and lymphocytes, were found to be increased following primary infection with E. maxima. The 
greatest increase in LMN was observed at the end of the life cycle of the parasites and was 
possibly associated with lesion resolution. Increases in PMNs were observed before and after 
peak oocyst production. Decreased numbers of leukocytes were concurrent with the appearance 
of sexual stages in the life cycle of the parasite. The leukocyte response in chickens reinfected 
with the parasite was rapid and involved increases in PMN and lymphocyte numbers. Infiltration 
of PMN and lymphocytes into the intestinal mucosa was observed concurrently (ROSE et al. 
1979; LILLEHOJ 1993). Following challenge of immune birds, circulating blood lymphocytes 
(primarily T-cells) initially decreased and then increased. The predominant involvement of T-
cells was thought to indicate a protective role for that population (ROSE et al. 1984). 
2.9.5  Cytokines 
The lymphocytes, macrophages, and other effector cells act in harmony to secrete cytokines and 
proinflammatory molecules, mediating the appropriate immune responses to the invading 
parasite. In contrast to the mammalian cytokines, only a few chicken homologues have been 
described, the main ones being interferon (IFN)-γ, transforming growth factor (TGF), tumor 
necrosis factor, interleukin (IL)-1, IL-2, IL-6, IL-8, and IL-15 (LILLEHOJ et al. 2004). 
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Recently, a number of cytokines including IL-17, IL-18, IL-16, IL-12, IL-10, and the Th2 type 
IL-3, IL-4, IL-13, granulocyte macrophage colony stimulating factor, and IL-5 have been 
described in chicken (DALLOUL and LILLEHOJ 2005). These cytokines could be participants 
in the immune responses to coccidiosis. Although not fully characterized, IL-1 association with 
E. tenella and E. maxima infections has been described (LAURENT et al. 2001). 
As it stands, Th1 responses seem to be dominant during coccidiosis, as best manifested by 
proven involvement of IFN-γ (DALLOUL and LILLEHOJ 2005). IL-10 was reported to induce 
inhibition of IFN-γ during E. maxima infection, suggesting that IL-10 may favour a shift to Th2-
type immunity in response to coccidiosis (ROTHWELL et al. 2004). This furthers our 
understanding that strong Th1-type, IFN-γ–driven immune responses are the dominant players 
during Eimeria spp. infections. 
2.10  Species determination and diagnosis 
Generally, the five most pathogenic species E. acervulina, E. brunetti, E. maxima, E. necatrix, 
and E. tenella can be differentiated in the host on the basis of clinical signs, characteristic lesions 
at particular sites of infection in the chicken intestine, and consideration of the prepatent period, 
size of oocysts, and morphology of intracellular stages. However, the less pathogenic species 
such as E. mitis and E. praecox might be overlooked. 
SHIRLEY (1975) was the first to use a molecular biological approach to differentiate species on 
the basis of isoenzyme patterns of oocysts by starch block electrophoresis. ELLIS and 
BUMSTEAD (1990) were among the first to demonstrate that ribosomal RNA (rRNA) genes 
could be used to identify individual species through characteristic restriction fragment patterns. 
PROCUNIER et al. (1993) used a randomly amplified polymorphic DNA assay to differentiate 
E. acervulina and E. tenella and to detect within-strain differences. Recombinant DNA 
techniques have been used to discriminate different strains of E. tenella (SHIRLEY 1994) and to 
develop markers for precocious and drug-resistant strains. PCR amplification of internal 
transcribed spacer region 1 (ITS-1) from genomic DNA, which are located in-between 18s and 
5.8s ribosomal RNA fragments, has been used to detect and differentiate six Eimeria species 
(SCHNITZLER et al. 1998). Eight species (including E. hagani) are claimed to be differentiated 
using a two-step PCR procedure (TSUJI et al. 1997), and six Australian species have been 
characterized using a PCR-linked restriction fragment length polymorphism approach (WOODS 
et al. 2000b). These PCR methods should prove very useful for epidemiological surveys of avian 
coccidiosis. 
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SCHNITZLER et al. (1998, 1999) chose the ITS-1 as a target for PCR. Initially, genus-specific 
primers to conserved regions flanking the ITS-1 were used to amplify a product from each of the 
seven species of Eimeria. Seven different primer pairs were designed to unique sections of the 
ITS-1 sequence, one for each species. Other workers (LEW et al. 2003; SU et al. 2003) used a 
similar approach, employing genus-specific primers as a starting point, cloning and sequencing 
the ITS-1 region, and then designing species-specific primers. The above studies employed one 
of two methods for the detection of the amplicons produced. Typically, PCR products underwent 
electrophoresis on ethidium bromide stained agarose gels, their sizes being displayed 
(SCHNITZLER et al. 1998; LEW et al. 2003; SU et al. 2003). While agarose gels allow the 
resolution of a PCR product based on size, they are limited in their ability to display sequence 
variation among amplicons, unless it relates to a considerable length difference. SCHNITZLER 
et al. (1999) also used a paper chromatography hybridization assay (PCHA) for the detection of 
amplicons. 
Using the first and second internal transcribed spacers of ribosomal DNA (ITS-1 and ITS-2), 
PCR-based electrophoretic methods for diagnosis and analysis of genetic variation were 
established. In Australia, Eimeria spp. from chickens were characterised using a polymerase 
chain reaction-linked restriction fragment length polymorphism (PCR-RFLP) approach; 
electrophoretic analysis of restriction endonuclease-digested radio-labelled ITS-2 amplicons was 
done in a denaturing polyacrylamide gel matrix (for six species of Eimeria) (WOODS et al. 
2000b). 
Denaturing polyacrylamide gel electrophoresis (D-PGE) and single-strand conformation 
polymorphism (SSCP) analyses were established for the display of sequence variation both 
within and among amplicons, produced from the ITS-1 and ITS-2 ribosomal DNA regions using 
a single set of genus/family-specific, radio-labelled oligonucleotide primers (for five species of 
Eimeria) (WOODS et al. 2000a). 
Electrophoresis of amplicons produced from the ITS-2 using a single primer set (one of which is 
fluorescence-labelled) can be used for the specific identification of and differentiation among all 
seven currently recognized species of Eimeria, and for the detection of variation within species 
(GASSER et al. 2001; GASSER et al. 2005). 
Recently, BLAKE et al. (2008) described the development of three other diagnostic real-time 
PCR assays, also based on sequence-characterized amplified regions (SCARs), for the specific 
detection of E. tenella, E. acervulina and E. necatrix. Recently another Real-time PCR assay has 
been established for the detection and quantification of seven species of Eimeria that infect 
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chickens in Australia. The assay targets one genetic marker, the second internal transcribed 
spacer of nuclear ribosomal DNA (ITS-2), makes use of TaqMan® MGB technology with 
species-specific probes, and can be multiplexed in pairs such that the seven species of Eimeria 
can be screened in four reaction tubes (MORGAN et al. 2009). 
2.11  Control of coccidiosis in chickens 
2.11.1  Management 
It is very difficult to keep chickens coccidia free, especially under current intensive rearing 
conditions, because Eimeria oocysts are ubiquitous and easily disseminated in the poultry house 
environment and have a large reproduction potential. Oocysts sporulate readily in poultry house 
litter, however, bacteria, other organisms, and ammonia that are also present can damage them, 
and their viability can begin to diminish after 3 weeks (WILLIAMS 1998). Disinfection alone is 
not an effective control measure but good sanitation practices allow for the mechanical removal 
of oocysts from the environment, thus decreasing exposure. However, reliance on this as a sole 
control method is not recommended as it is not effective in reducing disease (LONG et al. 1982). 
Many producers in the United States basically remove caked litter, let the houses air out for 2 to 
3 weeks, and top dress with fresh litter before placing a new flock (H. D. Danforth, private 
communication). On the other hand, it is common practice in most European countries to do a 
thorough cleanout between flocks. This practice may become more widespread as the 
effectiveness of anticoccidials continues to decrease and the use of live vaccines increases. 
Hygienic measures such as requiring caretakers to change clothes between houses can reduce the 
spread of infective oocysts. The practice of strict biosecurity is essential in the care of broiler 
breeders (ALLEN and FETTERER 2002). 
2.11.2  Immunobiology 
Day-old chicken can derive passively transferred protective immunity from the immunized hen 
by gametocyte surface antigens of E. maxima (WALLACH et al. 1992), however, birds of any 
age are principally susceptible to coccidiosis. In practise, most acquire infection in the first 
weeks of life and this infection induces a good immunity, which persists for life in most cases 
(DANFORTH 1998). A cardinal feature is that immunity is species specific. Thus, in chickens 
for example, immunity to E. tenella does not confer resistance to E. maxima or other species 
(MCDOUGALD 2008). Within species there appears to be remarkably little strain variation and 
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strains of the same species isolated from widely separated locations will provide substantial 
protection against other isolates of the same species with exception of E. maxima and E. 
acervulina (MCDOUGALD et al. 1997). Immunity is best maintained by repeated exposure to 
low number of oocysts, so-called trickle infection (NAKAI et al. 1992). Immunity is manifest as 
a reduction in lesions and a marked reduction in oocyst output due to both a reduction in the 
number of sporozoites that successfully invade host cells and inhibition of intracellular 
development of those that do (MCDOUGALD et al. 1997). The effectors of immune response to 
primary and challenge coccidial infections are primary T cells residing in the gut associated 
lymphoid tissues (GALT). Humoral immune (IgA) responses also occur, but antibodies play a 
minor role in resistance and immunity to coccidia (CHAPMAN 1999). 
2.11.3  Immunization 
The development of drug resistance in Eimeria has necessitated the development of other means 
of control. Immunological control through vaccination is the main current alternative. Species-
specific immunity is induced by controlled inoculation with oocysts of that species (LONG et al. 
1982). 
According to MCDOUGALD et al. (1997) vaccines must contain all the important species 
because of the species specificity of immunity. Following vaccination strategies are currently 
practised; 
• Natural infection from litter is relied on to induce immunity and serious disease is prevented by 
the use of drugs of modest efficacy or by using “step-down” doses programs in the first weeks of 
life (WILLIAMS 1998). 
•Live unattenuated vaccines are available in North America comprising mixtures of unattenuated 
lines of oocysts of all important species delivered in drinking water. This vaccine approach has 
had only limited popularity and it has not been used in Europe (SHIRLEY et al. 2005). 
•Live, attenuated vaccines: All seven pathogenic Eimeria species of chickens have been 
attenuated by rapid passage in vivo, selecting so-called “precocious” strain. Although these 
strains have lost virulence, they remain immunogenic. ParacoxTM (Schering-Plough Animal 
Health) contains 8 precocious lines (shortened life cycles) of the parasites, including seven 
species with two strains of E. maxima. Also LivacoxTM (Biopharm) contains attenuated lines of 
E. acervulina, E. maxima and E. tenella. Attenuated lines of the parasites are developed through 
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selection for precociousness. This trait is stable and heritable and results in reduced 
pathogenicity and increased sensitivity to anticoccidials (SHIRLEY et al. 2005). 
•Non-living vaccines. This vaccine is not yet available but it remains a subject of considerable 
research (SHIRLEY et al. 2005). 
Protection, as measured by increased weight gain, reduced lesion scores and reduced oocyst 
output, was found to be optimal following oral administration of the vaccine by gel delivery 
(DANFORTH 1998). 
Vaccines are now being used commonly in the breeder replacement layer industries, but not 
widely in the broiler-heavy roaster industry (DANFORTH 1998; ALLEN and FETTERER 2002; 
DALLOUL and LILLEHOJ 2005). Vaccines are not preferable for broilers due to an inability of 
the birds to compensate for the period of reduced weight gain that occurs following vaccine 
administration. For effective development of protection in broilers, exposure to the parasites 
must occur by 1day of age. However, Paracox® vaccine (Schering–Plough Animal Health) has 
already been used in over 240 million broiler breeders, layer replacements and heavy meat birds 
(WILLIAMS 1998). 
2.11.4  Chemotherapeutic agents 
Chemotherapeutics in use today are broadly classified as synthetics (chemically synthesized 
compounds) and ionophorous antibiotics (compounds produced through microbial fermentation) 
(CHAPMAN 1999). Chemotherapeutic strategies include the complete suppression of disease 
(broiler flocks), treatment of outbreaks and partial suppression of disease to allow for 
development of immunity (layer flocks). At present no single drug is effective in all three roles 
(RIDDELL 1984). 
The sulfonamides and related drugs compete for the incorporation of folic acid. Amprolium 
competes for absorption of thiamine by the parasite. The quinoline coccidiostats and clopidol 
inhibit energy metabolism in the cytochrome system of the coccidia. The polyether ionophorous 
upset the osmotic balance of the protozoan cell by altering the permeability of cell membranes 
for alkaline metal cations (JEFFERS and BENTLEY 1980). 
The coccidia are labile to be attacked by drugs at various stages in the development in the host. 
Totally unrelated drugs may attack the same stage of parasite. The quinolones and ionophorous 
drugs arrest or kill the sporozoite or early trophozoite. Nicarbazin, robenidine and zoalene 
destroy the first- or second-generation schizont, and the sulfonamides act on the developing 
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schizont and probably against sexual stages. Diclazuril acts in early schizogony with E. tenella 
but is delayed to later schizogony with E. acervulina and to the maturing macrogamet with E. 
maxima (CHAPMAN 1999). 
2.11.5  Drug resistance 
Anticoccidial resistance arises due to continued reliance on medication, use of suboptimal levels 
of drug, as well as the short life cycle of the parasites (RIDDEL 1984). The rapid asexual 
multiplicative cycles are characteristic of the coccidia and the inclusion of sexual recombination 
in the life cycle contributes to the relatively rapid development of drug resistance (LONG 1982). 
It has been fully studied (CHAPMAN 1994 and 1998; RUFF et al. 1976, BAFUNDO et al. 
2008), that some degree of resistance to all anticoccidial drugs, including ionophores, has been 
developed. To minimize the effects of resistance, poultry producers rotate the use of various 
anticoccidials with successive flocks, combine chemical and ionophore treatments, or employ 
shuttle programs during a flock grow out. Two new potential drug targets, enzymes of the 
sporozoite mannitol cycle (ALLOCCO et al. 1999; SCHMATZ 1997) and trophozoite histone 
deacetylase, have been identified (SCHMATZ 1997). Drug residues in the poultry products are 
potentially annoyed by consumers (YOUN and NOH 2001). Therefore other alternative 
treatments such as medicinal plant use in coccidiosis control must be envisaged, since 
coccidiosis was reported to be the most important parasitic disease chicken (KUSINA and 
KUSINA 1999). 
2.11.6  Feed additives and plant natural products 
Many different types of substances have been investigated in the search for alternative control of 
coccidiosis. Fish oil and flaxseed oil diets significantly reduced the degree of parasitism and 
development of E. tenella (ALLEN et al. 1996) and caused ultrastructural degradation of both 
asexual and sexual stages, characterized by cytoplasmic vacuolization, chromatin condensation 
within the nucleus, and lack of parasitophorous vacuole delineation (DANFORTH et al. 1997).  
Feed supplementation with antioxidants such as alpha-tocopherol (8 ppm), found plentifully in 
seed oils such as wheat, corn, and soybean, and the spice turmeric (1%), as well as its main 
medicinal component, curcumin (0.05%), appear effective in reducing upper- and mid-small 
intestinal infections caused by E. acervulina and E. maxima (ALLEN et al. 1998). They are not 
beneficial for E. tenella infections, however. Artemisinin is a chinese herb isolated from 
Artemisia annua; it is a naturally occurring endoperoxide with antimalarial properties. It has 
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been found effective in reducing oocyst output from both E. acervulina and E. tenella infections 
when fed at levels of 8.5 and 17 ppm in starter diets (ALLEN et al. 1997). The mode of action is 
also thought to involve oxidative stress. 
In Thailand, NAIYANA (2002) used Andrographis paniculata leaf powder in the feed and found 
a significant reduction of mortality rate as well as of the lesion scores in comparison to control 
groups. 
Recently, extracts from 15 asian herbs were tested for anticoccidial activity against E. tenella. Of 
the species tested, extracts from Sophora flavescens Aiton was the most effective in reducing 
lesion scores, maintaining body weight gain, and reducing oocyst production (YOUN and NOH 
2001). 
2.12  Transgenic plants 
Mass vaccination programmes led to significantly lower consumption of veterinary drugs, 
including antibiotics and reduced negative environmental impacts by eliminating chemical 
residues in products such as milk, eggs and meat. Production losses caused by illnesses can be 
avoided (FLOSS et al. 2007). The modern biotechnology has provided the opportunity to 
develop and produce protein pharmaceuticals in plants which offer inexpensive 
biopharmaceutical production with maintaining product quality and safety and the material can 
be delivered without extensive purification. However, the development of plant-based vaccines 
for animal health is more progressive than that for human health due to the stringent regulation 
to be followed for human medical products (METT et al. 2008) 
Medically relevant proteins expressed in plants can roughly be divided into three functional 
categories: (i) vaccines, (ii) recombinant antibodies, and (iii) other medical proteins, including 
blood products, growth factors, cytokines, enzymes, and structural proteins. 
The first recombinant plant derived pharmaceutical protein, human serum albumin, was 
produced in transgenic tobacco in 1990 (METT et al. 2008). There is some public concern 
regarding glycoproteins made in plants but there was no observation for undesirable symptoms 
after evaluating several plant-made glycoproteins, including monoclonal antibodies, in different 
animal models (METT et al. 2008). 
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Developing a plant-based vaccine 
In the absence of a currently used antigen, a suitable protein target, such as toxin subunits or 
surface antigens related to the pathogen of interest, must be selected. Known protective subunit 
vaccine and established vaccine antigen can be expressed in transgenic plants, an alternative oral 
option will be considered for reasons of cost (STREATFIELD 2007). When dealing with a 
poorly characterised pathogen, a genomics or proteomics approach might first be used to identify 
antigen candidates that possess promising characteristics (e.g. cell surface virulence factors). 
Several different plant species have been experimented for the purpose of expressing antigens at 
high levels. The most common plant chosen as an expression host is tobacco because it is 
relatively easy to transform and successful expression can be assessed quickly. However, in 
industry more focus has been placed on plant species, such as cereals, that offer long-term 
stability of the expressed protein, are cost effective, rapidly produce large volumes of the desired 
product, and can be easily processed into a deliverable form for oral vaccination (especially 
against diseases that are not lethal but diminish animal welfare and growth rate) 
(STREATFIELD and HOWARD 2003; STREATFIELD 2007; RYBICKI 2009) 
Vaccine antigens have been expressed in fresh tissues such as mature leaves (MASON et al. 
1992), fruits (MCGARVEY et al. 1995), tubers (HAQ et al. 1995), and taproots (BOUCHE et al. 
2003), and in dry tissues, including mature seeds (STREATFIELD et al. 2001). Harvested fresh 
plant tissues usually need processing to preserve the antigen in a stable form, while mature seeds 
are desiccated and allow long-term storage at ambient temperatures. However, fruits, tubers, and 
taproots can be stored for a limited time, especially in a chilled environment. Vaccine antigens 
have also been expressed in undifferentiated plant cell cultures such as cell suspensions (SMITH 
et al. 2002) and callus cultures (KAPUSTA et al. 1999), although these systems are not 
competitive in the bulk scale production needed for oral vaccine applications.  
Four different methods are now generally used for the production of recombinant proteins 
(HORN et al. 2004): Generation of stable nuclear transgenic plants, transplastomic plants, 
transient expression using a plant virus and transient expression via Agrobacterium infiltration. 
Animal enteric diseases are a particularly attractive target for edible plant-produced vaccines. 
Optimal protective mucosal immune response will be achieved when the vaccine is administered 
by the same route as the infection enters the body (DOUGAN 1994). Oral delivery offers ease of 
application and, by the induction of mucosal immunity, protection against pathogens interacting 
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with host mucosal surfaces (STREATFIELD 2005). In contrast, the immunisation of animals via 
injection lead to a systemic immune response. 
Sufficient expression levels are essential for economic viability of recombinant protein 
production to allow for oral delivery of the required antigen dose. Currently, the expression 
levels for most pharamaceutical proteins in the transgenic plants are less than that needed for 
commercial demands. Growing sufficient quantities of transgenic plants to meet large-scale 
production needs often requires outdoor field growth, raising regulatory concerns over 
containment (GOLDSTEIN and THOMAS 2004). 
Purification is the most obvious next step for proteins expressed in a plant tissue culture 
fermentation system or in plants grown under hydroponics, where the protein is secreted from 
the roots. Proteins have been purified from plants and are already being produced on a large-
scale for sale in fine chemical markets, most notably with the first large-scale commercial 
product, trypsin produced in corn (WOODARD et al. 2003). The protein purification approach is 
possible for candidate vaccine antigens expressed in recombinant plants, in which case a purified 
antigen could be delivered by any chosen means, including injection. However, this approach is 
likely to be prohibitively expensive for animal vaccines, and to properly realise the economic 
potential of plant-based vaccines it is necessary to pursue an oral delivery option based on a 
native or processed form of the plant material. 
Application of plant-based vaccines for animal diseases 
Viral diseases: ZHOU et al. (2003) successfully developed an edible potato-based vaccine 
against Infectious bronchitis virus (IBV) and the orally immunized chickens developed a virus-
specific antibody response and were protected against IBV. (WU et al. 2004) succeeded in 
vaccinating chickens orally with arabidobsis crude extracts against Infectious bursal disease 
virus (IBDV) and the chickens were protected in a manner similar to their counterparts, who had 
received a commercial injectable vaccine. Immune responses were elicited in laboratory animals 
after oral vaccination by transgenic plants (lettuce and alfalfa) expressing the E2 glycoprotein of 
Classical Swine Fever Virus (CSFV) or cysteine protease from Fasciola hepatica (LEGOCKI et 
al. 2005).  
Complete antigenic proteins, as well as peptides representing major antigenic determinants, have 
been produced in plant systems. In the case of vaccination against viruses, proteins located at the 
virion surface are generally the most suitable targets for an efficient immune response. 
Numerous veterinary vaccines, mainly against virus infections, have been expressed in plants. 
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Examples are Foot-and-Mouth-Disease (SANTOS et al. 2005), Rinderpest Virus 
(KHANDELWAL et al. 2003a; KHANDELWAL et al. 2003b), and Rotavirus (SALDANA et al. 
2006). 
Recently, achievements in the development of a plant-produced vaccine against avian Newcastle 
disease virus have been reported. Cucumber mosaic virus was utilized as a platform to display 
epitopes from virus surface glycoproteins. Chimeric virus particles were assembled in tobacco 
leaves, but their immunogenicity was not determined (ZHAO and HAMMOND 2005). 
(BERINSTEIN et al. 2005) chose another approach, using transgenic potato plants to express the 
same surface antigens in full length. Mice fed with the potato leaves or injected with leaf extracts 
showed virus-specific antibody responses. 
Parasitic diseases: A recombinant tobacco mosaic virus (TMV) with its capsid protein fused to 
a malarial peptide. Tobacco plants systemically infected contained high titers of genetically 
stable recombinant virus, enabling purification of the chimeric particles in high yield enough for 
production of subunit vaccines (TURPEN et al. 1995). Plant-based recombinant chicken sIgA 
was expressed in Tobacco (N. benthamiana) leaves and induced immune protection against 
coccidiosis (WIELAND et al. 2006).  
(CLEMENTE et al. 2005) used two constructs of Toxoplasma gondii Surface antigen 1 based in 
a potato virus X (PVX) amplicon were expressed in Agrobacterium-mediated transient 
Nicotiniana tabacum and found to be protective and immunogenic by subcutaneous delivery to 
mice. T. gondii multiple antigenic gene (Tg-MAG) recombinant protein with good immune 
activity was expressed successfully in transgenic tomato fruits (ZHOU et al. 2008). 
Bacterial diseases: bacterial infectors have also been chosen as targets for recombinant 
vaccines, e.g. B. anthracis (AZIZ et al. 2002; WATSON et al. 2004; AZIZ et al. 2005), E. coli 
(KANG et al. 2003; LEE et al. 2004), or M. tuberculosis (JOENSUU et al. 2004; ZELADA et al. 
2006). 
(For more examples see (STREATFIELD and HOWARD 2003; STREATFIELD 2005; 
STREATFIELD 2007; FLOSS et al. 2007; METT et al. 2008; RYBICKI 2009). 
2.13  Production of recombinant antibodies against Eimeria spp. using different 
expression systems, including transgenic plants 
Many researcher over the last years have attempted to develop a subunit coccidiosis vaccine 
using recombinant antigens expressed from DNA of various developmental stages (sporozoites, 
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merozoites, gametes) of Eimeria spp. (JENKINS 1998; VERMEULEN 1998). These DNA 
sequences have been expressed in a variety of prokaryotic and eukaryotic vectors, but 
immunization has only elicited partial protection against oocyst challenge (JENKINS 1998; 
VERMEULEN 1998). The reason for failure to stimulate protective immunity is unknown, but is 
probably related to either the use of a “non-protective” antigen or to inappropriate delivery of the 
vaccine to the mucosal immune system. Studies of resistance elicited by infection with virulent, 
irradiated, or drug-arrested Eimeria spp. suggests that sporozoite-infected cells are necessary for 
the development of protective immunity (JENKINS et al. 1991a; JENKINS et al. 1991b; 
JENKINS et al. 1993a; JENKINS et al. 1993b). There is also evidence for merogonic stages 
inducing and being targeted by protective immunity (ROSE and HESKETH 1979; MCDONALD 
et al. 1988). 
Recombinant antigens of avian coccidia have been derived generally from cDNA arising from 
mRNA of extracellular stages of the parasite (sporozoites, merozoites). It is likely that CD4+ and 
CD8+T cell responses during primary and secondary infections are directed against antigens 
expressed by parasite-infected cells. Thus, intracellular processing would be required for the 
presentation of recombinant antigen to the avian immune system. Supporting this idea is a recent 
finding that recombinant E. tenella sporozoite antigen was protective only if administered to 
chickens by direct DNA vaccination (KOPKO et al. 2000). Delivery of recombinant Eimeria 
antigens using Salmonella, fowl pox virus (FPV), or herpes virus of turkeys (HVT) expressing 
Eimeria DNA sequences may be a viable approach to protect chickens against coccidiosis 
(VERMEULEN 1998). These vectors have been shown to elicit CD4+ and CD8+ T cell 
responses in infected cells (RAMSAY et al. 1999). Recombinant chicken secretory IgA has been 
proposed as a potential means for passive immunisation against coccidiosis. IgA, assumed to 
have a role in the protection of mucosal surfaces (see above; Antibody responses to Eimeria 
spp.), was expressed in Tobacco (N. benthamiana) leaves and induced immune protection 
against coccidiosis (WIELAND et al. 2006).  
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3       Animals, material and methods 
3.1  Animals 
One day old unsexed CobbTM chicken (CobbTM, Germany) were kept under pathogen free 
conditions. The poultry house was disinfected with 4% Neopredisan® 135-1 (25% chlorocresole, 
Menno Chemie, Norderstedt, Germany) for 2 h (as listed in guidelines of DVG, the German 
Veterinary Society).  
The chicken were bred in groups (each group representing 10 chicken) in batteries with free 
access to food and water under coccidia free conditions. The faeces of the chicken were 
examined on the day of infection to exclude accidental coccidia infection. During the single 
oocyst infection trials the individual chicken were completely separated from each other. Over 
the whole study period, faecal samples were collected in separated plastic bags to be tested 
individually.  
3.2  Parasite 
For the infection trials Eimeria tenella (isolate LE-01 Eten-05/1), Eimeria brunetti (isolate LE-
04 Ebru-06/1), Eimeria acervulina (isolate LE-02 Eacer-05/1) and Eimeria maxima (isolate LE-
03 Emax-05/1) were used. The chicken were infected orally at an age of 2-3 weeks with a dose 
of 1,500 – 2,000 oocysts / chicken. 
3.2.1  Single oocyst infection 
Instruments 
Glass slides (Heiland, Hamburg, Germany) 
Microscope (CX31, Olympus Optical, Hamburg, Germany) 
Glass diamond pen 
Autoclave (Varioklav 25 T, H+P Labortechnik, Oberschleißheim, Germany) 
Single use wood spatula, plastic pails and plastic sieves 
Material 
Gelatin capsules (size 2, G29202, Plano GmbH, Wetzlar, Germany) 
Cooking gelatin 
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Two methods were used for single oocyst infection: 
Method 1: The glass slides were divided into very small cubics (circa 1 x 1 mm2) by using a 
glass diamond pen. The cubics were marked with different letters and numbers. A first layer of 
prewarmed liquid 5% gelatin was spread over the divided slide and kept 10 min at 4°C to 
solidify. A mixture of 0.5 ml prewarmed liquid 5% gelatin and 0.5 ml oocyst suspension (100 
oocyst / ml) was spread over the first layer and kept at 4°C for 10 min. The slide was examined 
microscopically and separated single sporulated oocysts were cut from the slide. Single oocysts 
were placed into a gel capsule and introduced into the esophagus followed by some drops of 
water. 
Method 2: one ml of oocyst suspension containing 100 oocysts was diluted into 10 ml water. 
Every chicken was inoculated orally with a volume of 100 µl which assumingly contained one 
oocyst. The chicken were bred individually to avoid cross contamination between the different 
isolates.  
The fecal samples were collected separately and examined individually using single use 
equipments or cleaned, disinfected and autoclaved materials. The oocysts were recovered from 
the fecal samples by precipitation and floatation (see 3.2.2.). 
3.2.2  Recovery of oocysts 
Instruments 
Cascade sieves with different pore size from the top to downward (300 µm, 200 
µm, 100 µm, 65 µm and 36 µm; Analysette 3, Fritsch, Idar-Oberstein, Germany) 
Electric pipetting aid ( Pipetus-akku, Hirschman Laboratory equipments, 
Eberstadt, Germany) 
Centrifuge (Rotina 46, Hettich GmbH, Tuttlingen, Germany) 
Microscope (CX31, Olympus Optical, Hamburg, Germany) 
Shaking plate (Rocky RT-N/G/2, LFT-Labortechnik, Wasserburg, Germany) 
Hand-hold blender (MR 305, Braun, Kornberg, Germany) 
Materials 
Sodium chloride, saturated solution with a specific gravity of 1.200 
Potassium dichromate 4%  
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The fecal samples were collected after the prepatency for each Eimeria species. The samples 
were daily collected in one 5-liter pail and homogenized thoroughly with a hand-hold blender, 
then filtered using a system of cascade sieves. The usage of cascade sieves helped to concentrate 
and partially purify the oocyst suspension. The suspension was centrifuged at 700x g for 10 min. 
The sediment was resuspended with saturated salt solution and centrifuged at 700 x g for 10 min. 
The resulting supernatant was examined microscopically. The oocysts were sucked off with an 
electric pipette, washed into water and centrifuged at 700 x g for 10 min. The collected oocysts 
were kept in potassium dichromate 4% on a shaking plate (27 – 30 rpm) to sporulate within 
about 3 days. 
3.2.3  Preparation and purification of sporozoites and merozoites 
3.2.3.1  Excystation of sporozoites 
Instruments 
Neubauer counting chamber (Roth, Karlsruhe, Germany) 
Phase contrast microscope (DM IRB, Leica, Bensheim, Germany) 
Vortex (Vortex-Genie 2, Scientific industries, USA) 
Water bath (W270, Memmert, Schwabach, Germany) 
Centrifuge (Megafuge 2.0 R, Haereus, Hanau, Germany) 
Materials 
Glass beads 0.5 mm (catalog # 11079105, Biospec Products, Bartlesville, OK, 
USA) 
Excystation medium: 1x Hanks Balanced Salt Solution (HBSS) (Biochrom), 
0.25% Trypsin (Roth, Karlsruhe, Germany), 2% sodium taurocholate (T-4009, 
Sigma, Taufkirchen, Germany). pH adjusted to 7.4 by using 7.5% sodium 
carbonate (NaHCO3-AppliChem) 
Sodium hypochlorite 12% free chlorine (Roth, Germany) 
Distilled water 
Plastic test tubes (12 ml, 50 ml; Techno plastic products (TPP), Trasadingen, 
Switzerland) 
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Diagnostic slides (epoxy-coated divided into 12 wells, 5 mm diameter, 
X1XER302W#MNZ, Diagnostika, MANZEL GLAESER, Braunschweig, 
Germany) 
1x phosphate buffered solution (PBS, pH 7.6): Na2HPO4 13.48 g/l, NaH2PO4 0.78 
g/l, NaCl 4.25 g/l 
The sporulated Eimeria spp. oocysts were washed three times with distilled water to remove 
potassium dichromate and centrifuged at 700 x g for 10 min. The oocyst pellet was incubated 
with sodium hypochlorite solution (4% active chlorine) on ice for 15 min. The oocyst suspension 
was centrifuged at 300 x g for 3 min. The supernatant was taken and the sediment which mainly 
consists of faecal debris was discarded. The oocyst suspension was washed with 50 ml PBS 3-5 
times to remove the chlorine by centrifugation at 1500 x g for 5 min.  
The oocysts were cracked with glass beads upon the vortex for 30-120 seconds according to the 
species. Cracking of oocysts was noticed microscopically every 10 seconds until all oocysts were 
destroyed and the sporocysts were free. If the sporozoites were seen, the cracking was stopped. 
The mixture of oocysts, sporocysts and sporozoites was transferred into another tube and 
centrifuged at 1500 x g for 5 min.  
The pellet was washed twice with PBS, then added to the excystation medium and incubated in a 
water bath at 41°C for 90-120 min. Excystation was controlled microscopically every 15 min. 
The excysted sporozoites were counted under the phase contrast microscope using Neubauer 
chambers. The sporozoites were either frozen at -196°C until use or transferred onto 12 well 
diagnostic slides with approximately 104 sporozoites per well. The slides were left to dry at room 
temperature, then kept at -80°C until used for indirect immunofluorescence. 
3.2.3.2  Recovery of merozoites 
Materials 
Incubation medium: 1x HBSS with 10 mM MgCl2 (Roth, Karlsruhe, Germany), 
0.25% Trypsin (Roth, Karlsruhe, Germany) and 1% Na taurocholate (T-4009, 
Sigma, Taufkirchen, Germany). This solution was sterilized by filtration 
1x phosphate buffered saline (PBS, ph 7.6): Na2HPO4 13.48 g/l, NaH2PO4 0.78 
g/l, NaCl 4.25 g/l 
Instruments 
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Heatable magnetic stirrer (MR3001 K, Heidolph instruments, Schabach, 
Germany) 
Ten chicken at age of 2 weeks were infected per os with 2 x 105 sporulated oocysts from each 
species as shown in table 1.2. 
 
Table1.2: Infection conditions to produce merozoites 
Eimeria spp. hours post infection dose of infection 
E. acervulina 80 h 200 x 10 3 
E. tenella 112 h 200 x 10 3 
E. maxima 110-120 h 50 x 10 3 
E. brunetti 110-120 h 200 x 10 3 
After the prepatent period, the infected birds were humanely killed by exposure to chloroform 
inhalation in a closed box for 5-10 min. The upper part of the small intestine from the gizzard to 
the yolk sac diverticulum (E. acervulina), caeca (E. tenella), the middle part of the small 
intestine (E. maxima) or the lower part of the small intestine, rectum and caeca (E. brunetti) was 
removed separately. 
The samples were cut into small pieces and stirred separatly in the incubation medium for 30 
min at 41°C at 250 rpm. The mixture was filtered through gauze to remove large particles. The 
filtrate was centrifuged at 700 x g for 5 min and then resuspended in PBS. 
The merozoites pellet was passed through an equal volume of DE-52 and purified (see 3.2.3.3). 
3.2.3.3  Purification of sporozoites and merozoites by DE-52 anion exchange 
chromatography 
Instruments 
pH meter 
Microfuge (Micro 20, Hettich GmbH, Tuttlingen, Germany) 
Refrigerator with freezer (+4/-20, Liebherr, Germany) 
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Materials 
Glass wool superfine (No. 1408/2, Assistant, Germany) 
Nylon wool fiber (Polysciences, Inc., Warrington, England) 
10 ml medical syringe 
DE-52 (Diethylaminoethyl Cellulose, Pre-Swollen Microgranular Anion 
Exchanger, Whatman International Ltd, Maidstone, England) 
1x PBS (pH 7.6) Na2HPO4 13.48 g/l, NaH2PO4 0.78 g/l, NaCl 4.25 g/l 
Elution buffer (pH 7.6): 1x PBS supplemented with 1% glucose 
Glas beaker (50 ml and 100 ml) 
DE-52 Equilibrium buffer: (1x PBS - 1% Glucose) 
Single use syringe (10 ml, B. Braun, Melsungen, Germany) 
1.5 ml microfuge tube (Roth, Karlsruhe, Germany) 
In a 100 ml beaker, 5g of DE-52 were mixed well with 50 ml of 1x PBS (pH 7.6) and allowed to 
settle for 1 h. The supernatant was poured off and more 1x PBS (pH 7.6) was added. This 
washing step was repeated 2-3 times. 
The DE-52 was resuspended in 1x PBS (pH 8) and kept overnight at 4°C. At the next day the 
supernatant was discarded leaving some fluid to avoid dryness of the DE-52.  
The DE-52-column was prepared by putting a small amount of glass wool into the nozzle of a 10 
ml syringe barrel. Nylon wool was added to a height of 3 cm. Few drops of buffer were used to 
wet the glass and nylon wool, then DE-52 was added to a height of 3 cm above the nylon wool. 
The DE-52 column was washed once with the elution buffer before use (dryness of the DE-52 
must be avoided). The suspension of zoites (sporozoites or merozoites) was added directly on the 
column and purified by elution buffer.  
The zoites were collected in 1.5 microfuge tubes and washed twice with 1x PBS (pH 7.6). The 
zoites were centrifuged at 7,000 x g for 5 min and the pellet was resuspended in 1 ml PBS before 
counting in a Neubauer slide. They were used directly or kept at -196°C until use. 
3.2.3.4  Purification of sporozoites by PercollTM gradient 
Instruments 
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Microfuge (Micro 20, Hettich GmbH, Tuttlingen, Germany) 
Materials 
1x PBS (pH 7.6): Na2HPO4 13.48 g/l, NaH2PO4 0.78 g/l, NaCl 4.25 g/l 
10x Hanks balanced salt solution (HBSS) (Biochrom) 
PercollTM (sterile) at a density of 1.13 g/ml (Pharmacia Fine-Chemicals, Uppsala, 
Sweden) 
PercollTM (density, 1.13 g/ml) was diluted to an osmolality of 340 mOsmol/kg H2O by adding 9 
parts (vol/vol) of 10x HBSS or 10x PBS. Further dilutions of the PercollTM solution were made 
with 1x HBSS or 1x PBS.  
The excysted sporozoites (in a suspension of oocysts, sporocysts and other debris; see 3.2.3.1.) 
were washed twice in 1x PBS and pelleted at 7,000 x g for 5 min. The pellet was resuspended in 
60% PercollTM and centrifuged for 1 min at 10,000 x g. The sporozoites were pelleted in the 
bottom while the sporocysts and other debris were mainly located in the most upper layer. The 
sporozoites were collected carefully from the bottom and washed 2-3 times with PBS. The 
collected sporozoites were counted and used directly or kept at -196°C until use. 
3.3  DNA preparation 
Instruments 
Ultrasound sonicator (Bandelin Sonopuls GM 70, Bandelin electronics, 12207 
Berlin) 
Stop watch (Roth, Karlsruhe, Germany) 
Vortex (Vortex-Genie 2, Scientific industries, USA) 
Microfuge (Micro 20, Hettich GmbH, Tuttlingen, Germany) 
Refrigerator -20°C (Liebherr, Germany) 
Thermomixer (Modell 5436, Eppendorf, Hamburg, Germany) 
Spectrophotometer (Eppendorf BioPhotometer, Eppendorf AG, Hamburg, 
Germany) 
Materials 
Sodium hypochlorite 12% free chlorine (Roth, Karlsruhe, Germany) 
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Absolute ethanol (Roth, Karlsruhe, Germany) 
Proteinase K 20 mg/ml (Roth, Karlsruhe, Germany) 
QIAamp® DNA Mini Kit (Qiagen, Hilden, Germany) 
The sporulated Eimeria spp. oocysts were washed three times with distilled water to remove 
potassium dichromate by centrifugation at 700 x g for 10 min. The oocyst pellet underwent 
surface sterilization (see 3.2.3.1). 
The oocyst pellet was mixed with 200 ATL buffer (QIAamp® DNA mini Kit) into a 1.5 ml 
microfuge tube and cracked with ultrasound sonicator at 50% power for 9 min. The DNA was 
extracted with QIAmp® DNA mini Kit as described in the manufacturer’s instructions. The 
concentration of the extracted DNA was measured at 260 nm using a spectrophotometer. The 
extracted DNA was used directly or kept at -20°C until use. 
3.4  PCR 
Instruments 
Thermocycler (iCycler®, Bio-Rad, München, Germany) 
Microcentrifuge (SD 220 VAC, Roth, Karlsruhe, Germany) 
Pipettes (10 µl, 100 µl, 1000 µl, PreCision® , Biozym Diagnostics, Hess. Olden-
dorf, Germany) 
Materials 
Magnesium chloride (MgCl2) solution (25 mM, Promega, USA) 
Deoxyribonucleotide (100 mM dATP, 100 mM dTTP, 100 mM dCTP and 100 
mM, Peqlab, Erlangen, Germany) 
PCR buffer (10x Promega, USA) 
Taq polymerase (5 U/µl, Promega, USA) 
Oligonucleotide primers (MWG-Biotech, Ebersberg, Germany) 
DEPC water for molecular biology (Roth, Karlsruhe, Germany) 
PCR tubes (100 µl, 200 µl, Roth, Karlsruhe, Germany) 
Pipette tips (10 µl, 100 µl, 1000 µl, Roth, Karlsruhe, Germany) 
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The PCR protocol to detect different chicken Eimeria spp. has been published by SCHNITZLER 
et al. (1998 and 1999) and SU et al. (2003) previously. The PCR reactions were prepared in a 
final volume of 25 µl consisting of 1x PCR buffer, 2 mM MgCl2, 200 µM of each 
deoxyribonucleotide, 300 nM of each oligonucleotide primers (see table 3.4.), one unit of Taq 
polymerase and 30-50 ng DNA template. 
The reaction cycles consisted of an initial denaturation step at 95°C for 3 min followed by 35 
cycles at 94°C for 45 seconds, annealing at a temperature of 61°C for 40 seconds (this 
temperature was used for all primers listed in table 3.4) and 72°C for 60 seconds, and a final 
extension cycle at 72°C for 10 min. 
3.4.1  Visualization of PCR products 
Instruments  
Electrophoresis chamber, gel form and comb (Biometra, Göttingen, Germany) 
Electrophoresis power supply (Powerpack P25, Biometra, Göttingen, Germany) 
Transilluminator with UV light of wavelength 254 nm (TFX-20M, Vilber 
Lourmat, France) connected to a PC-digital camera (CSE-0028, Cybertech, 
Berlin, Germany) and computer 
Rock plate (Rocky RT-N/G/2, LFT-Labortechnik, Wasserburg, Germany) 
Balance (BP310 P, Sartorius AG, Göttingen, Germany) 
Microwave ofen (MW712, CTC Clatronic, Kempen, Germany) 
Materials 
10x TBE buffer (1 liter: 108 g Tris base, 55 g Boric acid and 40 ml 0.5M EDTA), 
pH 8.0, autoclaved for 20 min 
Destilled water 
Deionized water 
Ethidium bromide stock solution 10 mg/ml (Sigma, Taufkirchen, Germany) 2 µl 
dissolved into 100 ml distilled water in a plastic container (0.2 µg/ml) 
Gel loading buffer: 2 ml glycerol, 4.4 ml TE buffer and 0.6 ml 1% (w/v) 
Bromophenol blue 
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(1x TE buffer: 10mM Tris-HCl pH 7.4 and 1mM EDTA pH 8.0) 
Agarose (preqGold Universal Agarose, Peqlab, Erlangen, Germany) 
Parafilm (American National Can, Menashs, Wisconsin, USA) 
Erlenmeyer bottles (100 ml, 500 ml) 
Graduated glass cylinders (50 ml, 100 ml, 500 ml) 
Method 
10 µl of PCR product were loaded onto 1.5 % agarose gel in 1x TBE buffer and separated by 
electrophoresis at 110-130 volts for 60-80 min. The gel was transferred to be stained in an 
aqueous ethidium bromide solution (0.5 µg/ml) for 15 min. The gel was shortly rinsed in 
deionized water to remove ethidium bromide. 
The gel was placed on the transilluminator (UV wavelength 254 nm) and DNA bands were 
visualized under UV light and photographed by digital camera. The pictures were captured and 
saved to the connected computer. 
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Table 3.4: List of PCR primers used in the current study 
 Sequence (5’-3’) 
length
 (b
ases)
 
T
a
*
 (
°C)
 
Location in genome 
P
rod
u
ct
 length
 (bp)
 
Reference 
BSEF CTGTGAATTCATCGGA 16 
BSER ATCGCATTTCGCTGCGTCCT 20 
61 ITS-1/ssrRNA-Gene of 
chicken-Eimeria  (SU et al. 2003) 
TEN1 CGCTGCTGGTTTTACAGGTT 20 
TEN2 GCTGAAGCAAAGTTCCAAGC 20 
61 ITS-1/ssrRNA-Gene E.tenella 463 (SU et al. 2003) 
ACER1 CTGCGAGGGAACGCTTAAT 19 
ACER2 AACGAACGCAATAACACACG 20 
61 ITS-1/ssrRNA-Gene of E.acervulina 303 (SU et al. 2003) 
BRUN1 AGCTTGGATTTTCGCTCAGA 20 
BRUN2 CTTCCGTACGTCGGATTTGT 20 
61 ITS-1/ssrRNA-Gene of E. brunetti 395 (SU et al. 2003) 
MAX1 TTGTGGGGCATATTGTTGTG 20 
MAX2 CAATGAGGCACCACATGTCT 20 
61 ITS-1/ssrRNA-Gene of E.maxima 151 (SU et al. 2003) 
NEC1 GTCACGTTTTTGCCTGGGTG 20 
NEC2 ACAGACCGCTACACAACACG 20 
61 ITS-1/ssrRNA-Gene of E.necatrix 385 (SU et al. 2003) 
EAceF GGCTTGGATGATGTTTGCTG 20 
EAceR CGAACGCAATAACACACGCT 20 
61 ITS-1 of E. acervulina 321 (SCHNITZLER 
et al. 1998; 1999) 
EBruF GATCAGTTTGAGCAAACCTTCG 22 
EBruR TGGTCTTCCGTACGTCGGAT 20 
61 ITS-1 of E. brunetti 311 (SCHNITZLER 
et al. 1998; 1999) 
ENecF TACATCCCAATCTTTGAATCG 21 
ENecR GGCATACTAGCTTCGAGCAAC 21 
61 ITS-1 of E. necatrix 384 (SCHNITZLER 
et al. 1998; 1999) 
ETenF AATTTAGTCCATCGCAACCCT 21 
ETenR CGAGCGCTCTGCATACGACA 20 
61 ITS-1 of E. tenella 278 (SCHNITZLER 
et al. 1998; 1999) 
EMaxF GTGGGACTGTGGTGATGGGG 20 
EMaxR ACCAGCATGCGCTCACAACCC 21 
61 ITS-1 of E. maxima 205 (SCHNITZLER 
et al. 1998; 1999) 
EMitF TATTTCCTGTCGTCGTCTCGC 21 
EMitR GTATGCAAGAGAGAATCGGGA 21 
61 ITS-1 of E. mitis 327 (SCHNITZLER 
et al. 1998; 1999) 
EPreF CATCATCGGAATGGCTTTTTGA 22 
EPreR AATAAATAGCGCAAAATTAAGCA 23 
61 ITS-1 of E. praecox 391 (SCHNITZLER 
et al. 1998; 1999) 
Eb_18s_S1 CCCATGCATGTCTAAGTATAAGC 23 
AP1_SSU 
_rDNA_A 
CACTGCCACGGTAGTCCAATAC 22 
56 RNA 18s of Coccidia 
specieses 300 
(DYACHENKO 
2006) 
*Ta is the annealing temperature. 
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3.5  Indirect Immunofluorescence test (IFAT) 
Sporozoites and merozoites were used as antigen and were prepared as explained before (3.2.3) 
Instruments 
Phase contrast microscope (DM IRB, Leica, Bensheim, Germany) 
Air dryer (Memmert, Schwabach, Germany) 
-20°C refrigerator (Liebherr, Germany) 
Materials 
Diagnostic slides (epoxy-coated divided into 12 wells, 5 mm diameter, 
X1XER302W#MNZ, Diagnostika, MANZEL GLAESER, Braunschweig, 
Germany) 
Thick cover glass 24 x 60 mm (Roth, Karlsruhe, Germany) 
Absolute methanol (Roth, Karlsruhe, Germany) 
1x PBS (pH 7.6) Na2HPO4 13.48 g/l, NaH2PO4 0.78 g/l, NaCl 4.25 g/l 
DAPI 300nM; the stock solution is dissolved in absolute methanol at a 
concentration of 2 mg/ml (2 µg/µl)  
Blocking buffer I: used for blocking of free-aldehyde groups consisting of 100 
mM glycin dissolved in 1x PBS (i.e., 0.7507 g in 100 ml PBS) 
Blocking buffer II: to block the non specific binding sites on the antigen 
consisting of 2% (w/v) bovine serum albumin (BSA, Roth, Karlsruhe, Germany) 
in PBS 
Antibody-incubation buffer: 1% BSA (w/v) in 1x PBS; antibody is added 
according to the desired concentration (1:10 or 1:100). 0.2% Evans Blue is added 
with the secondary antibodies 
4% buffered formaldehyde solution (w/v) as fixative (must be prewarmed to 50-
60°C before use; fixation at room temperature) 
Methanol 100% as fixative, kept at -20°C before and during fixation 
Mounting medium: 100 mg p-Phenylendiamin, 10 ml 1x PBS and 90 ml glycerol, 
pH 8.0; this medium is kept in the dark at -20°C 
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Primary antibodies 
Antibody fragments purified from transgenic pea plant and antibodies containing 
periplasmatic extracts of E. coli were kindly supplied by Novoplant (Novoplant 
GmbH, Am Schwabeplan 1b, 06466 Gatersleben, Germany), which are Ab1, Ab2, 
Ab3, Ab4, Ab5, Ab6, Ab7, Ab8 and Ab9. 
Rabbit anti-Eimeria bovis-calmodulin domain protein kinase-antiserum was used 
as positive control which was kindly provided by Dr. V. Dyachenko (Institute of 
Parasitology, University of Leipzig, Germany) 
Secondary antibodies 
Fluorescein (FITC)-conjugated goat anti-rabbit immunoglobulin, IgG (H+L) 
(code 111-0950003, Dianova, Jakson Immunoresearch laboratories) 
Un-conjugated monoclonal mouse anti-poly-histidin IgG clone His-1 (Sigma 
Aldrich, St. Louis, Mo, USA) 
Fluorescein (FITC) -conjugated goat-anti-mouse IgG, (Fcg-fragment specific, 
115-095-008, Dianova, Jakson Immunoresearch Laboratories) 
Method 
The slides with dried antigen were separated into two groups. The slides of the first group were 
fixed in 4 % buffered formaldehyde for 15 min at room temprature (RT). The second group of 
slides were fixed with pre-cold methanol at -20°C for 10-15 min, then were left 10 min to dry 
under air flow. 
Waxy or greasy pen was used to separate the antigenic spots or wells to avoid cross 
contamination. 
20 µl of blocking buffer I were added onto each antigen spot of formaldehyde-fixed slides. The 
slides were incubated in moistened Petri dishes at RT for 10 min. Then the slides were rinsed 3 
times in PBS and once in destilled water to remove the excess of PBS. The slides were left to dry 
for 10 min. 
Formaldehyde- and methanol-fixed slides were incubated in blocking buffer II (in a Petri dish 
with moistened tissue to avoid dryness) for 30 min at RT. Then the slides were rinsed 3 times in 
PBS and once in destilled water to remove the excess of PBS and left to dry for 10 min. 
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The primary antibodies were dropped (diluted 1:10, 1:50, 1:100 1:500 in incubation buffer) onto 
each antigen spot of the slide and incubated 60 min at RT. Then the slides were rinsed in 1x PBS 
for 10 min three times and once in destilled water and left to dry. 
Anti-poly-histidin IgG (diluted 1:100 in incubation buffer) was added followed by incubation for 
60 min at RT. Then the slides were rinsed in 1x PBS for 10 min three times and once in destilled 
water and left to dry. 
Conjugated antibody (FITC-conjugated goat-anti-mouse IgG) was dropped at a dilution of 1:100 
in incubation buffer containing 0.02% Evan’s blue as a counter stain. The slides were incubated 
with the conjugated antibodies for 60 min at RT. 
Then the slides were rinsed in 1x PBS for 10 min three times and once in destilled water and left 
to dry, but not completely. 
All spots were covered with 20 µl of DAPI solution (300 nM) for 3 min in a dark place at RT. 
The slides were washed twice 5 min with PBS and finally were washed with destilled water. 
Mounting medium (about 5 µl) was added to each spot. The slides were covered by a large thick 
cover glass avoiding entrance of air bubbles and sealed with nail paint. The slides were 
examined immediately or kept in a refrigerator at 4°C until examination. 
The control reactions were made as described above using following antibodies:- 
1st negative control: monoclonal antibody anti-poly-histidin and FITC-conjugated goat-anti-
mouse IgG. 
2nd negative control: only FITC-conjugated goat-anti-mouse IgG (without antibody fragments 
or anti-poly-histidin IgG). 
Positive control: rabbit anti-CDPK IgG and FITC-conjugated goat anti-rabbit IgG. 
3.5.1  Acquiring and processing of images 
Instruments 
inverted microscope (Leica DM IRB, Wetzlar GmbH, Bensheim, Germany). This 
microscope is equipped with a cooled camera head (DS-5Mc, Nikon, Japan) and 
liquid crystal display (Nikon DS-L1, Nikon, Japan) and is controlled by software 
that displays current settings and view. Also this microscope has a phase contrast 
facility and three different fluorescence filters (green, blue and red) 
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Software 
software package CorelDRAW® Graphics Suite 12 
Images were captured using the inverted microscope and digital camera. Pictures of each view 
were acquired using following filters: the red filter to visualize refractile bodies of sporozoites 
stained with Evan´s blue, the green filter to visualize antibody binding reaction and the blue filter 
to visualize DNA containing nuclei. The phase contrast view was used to visualize the whole 
parasitic cell. Pictures aquired with different modes were compared and taken under identical 
adjustments in respect of exposure time and magnification. The pictures were further processed 
using the computer software package CorelDRAW® Graphics Suite 12. In brief, overlays were 
created by addition of fluorescence pictures obtained with different filters. The blue fluorescence 
picture was considered as the background with applying a merge mode of ‘’Normal’’ while the 
pictures of green and red fluorescence were added on the background with a merge mode of 
‘’Logical Or’’ to keep them transparent. Then all pictures were combined to get finally one 
photo showing green, red and blue fluorescence and this was compared with the phase contrast 
view later to localize the regions of interest. 
3.6  Flow cytometry (FC) 
To estimate cells infected with fluorescent labeled sporozoites, flow cytometry was performed. 
Fluorescence activated cell sorting (FACS) is the most widely used method for selectively 
isolating cells based on their fluorescent markers. This method has already been successfully 
applied in a number of studies on invasion inhibition assay for Eimeria species (SCHUBERT et 
al. 2005; LABBE et al. 2005; HERMOSILLA et al. 2008) 
Flow cytometry is defined as the measurement of the cellular and fluorescent properties of cells 
in suspension as they pass by a laser or other light source (SHARROW 1991; HAWLEY and 
HAWLEY 2004). The measurements are represented by changes in light scattered, light 
absorbed, and light emitted by a cell as it passes by fixed detectors directed off the light source. 
From these measurements, specific populations and subsets within them are defined.  
Prior to this procedure, the cell cultures were grown (see 3.6.1), infected with CFSE-labelled 
sporozoites, incubated for 24 h at 37°C and 5% CO2, trypsinised and washed in PBS. Thereafter 
the infected cells were fixed with 2% buffered formaldehyde for 10 min. 
As the cells pass through the cytometer, all light signals, whether from fluorescently labelled 
cells or from the beam scattered by unlabeled cells, are transferred to a computer and 
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transformed into digital signals. These signals can then be displayed as histogram graphs or, as 
two-dimensional graphs called dot-plots. In these diagrams, one parameter is plotted against 
another in an X versus Y axis display (see Results, figure 4.4).  
Parasite 
purified sporozoites of Eimeria tenella (see 3.2.3). 
Instruments 
FACScalibur cytometer (Becton-Dickinson Biosciences, Heidelberg, Germany) 
equipped with an argon laser. A standard filter setting was used. Laser excitation 
wave lengths were 488 nm for the green fluorescence (CFSE). In each sample, 
20,000 events were analysed for fluorescent signals using the associated software 
Cell Quest ProTM (BD Biosciences, Heidelberg, Germany) 
Materials 
CFSE; carboxy fluorescein succinimidyl ester (Cell TraceTM CFSE cell 
proliferation kit for flow cytometry, Cat# C34554, Invitrogen, Technologiepark 
Karlsruhe, Germany) 
Accutase™ (CatNo. L11-007, PAA Laboratories, Cölbe, Germany) alternative to 
Trypsin/EDTA for the detachment of monolayer cells from surfaces suitable to 
reduce clumping in cell suspension used for counting 
1x PBS with calcium and magnesium (washing buffer): 100 ml of PBS Ca2+ and 
Mg2+ containing 1mM CaCl2 (0.015g) and 0.5 mM MgCl2 (0.010g) 
Dulbecco’s modified Eagle’s medium (DMEM), high glucose (4.5 g/l), with 1% 
sodium pyruvate and L-glutamine (CatNo. E15-843, PAA Laboratories, Cölbe, 
Germany) 
Newborn calf serum (NCS, CatNo. B11-001, PAA Laboratories, Cölbe, Germany) 
HEPES buffer (CatNo. S11-001, PAA Laboratories, Cölbe, Germany) 
Fixation buffer; 10% formaldehyde buffered solution: paraformaldehyde 
dissolved in 10x PBS by at 60-70°C during stirring , pH 7.4. The buffer was 
stored in a refrigerator as stock solution. It was warmed before use and diluted in 
distilled water 1:10 before used for fixation of cells. The fixed cells were stored at 
4°C in a refrigerator in the dark until use. 
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96-well plates with V-bottom (Cat# 9292.1, Carl Roth, Karlsruhe, Germany) 
3.6.1  Cell culture and growth conditions 
Instruments 
Autoclave (Varioklav 25 T, H+P Labortechnik, Oberschleißheim, Germany) 
Laminar flow (HERAsafe K 12, Kendro, Hanau, Germany) 
CO2 incubator (CB 150, Binder, Tutlingen, Germany) 
Inverted phase contrast microscope with fluorescence equipment (DM IRB, Leica, 
Bensheim, Germany) 
Vortex (Vortex-Genie 2, Scientific Industries, USA) 
Water bath (W270, Memmert, Schwabach, Germany) 
Centrifuge (Megafuge 2.0 R, Haereus, Hanau, Germany) 
Electric pipetting aid (Pipettus-akku, Hirschaman Laborgeraete, Eberstadt, 
Germany) 
Liquid ring vacuum pump (VacuSafe®, Integra Biosciences, Fernwald, Germany) 
Materials 
Glass pasteur pipettes (150 mm, unplugged, Roth, Karlsruhe, Germany) 
Cell culture bottles 75 cm2 (TPP, Trasadingen, Switzerland) 
Cell culture 24-well plates (TPP, Trasadingen, Switzerland) 
Graduated glass pipettes (5 ml, 10 ml, 25 ml; Roth, Karlsruhe, Germany) 
Centrifuge tubes with clockwise stopper (12 ml, TPP, Trasadingen, Switzerland) 
Syring attachable filter (0.2 µm, 0.8 µm; Renner, Darmstadt, Germany) 
Cryogenic tubes (Roth, Karlsruhe, Germany) 
Wiping tissues (Roth, Karlsruhe, Germany) 
Latex gluves (Roth, Karlsruhe, Germany) 
Ethanol 70% 
Neubauer counting slide (Roth, Karlsruhe, Germany) 
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Accutase™ (CatNo. L11-007, PAA Laboratories, Cölbe, Germany) 
1x PBS (pH 7.6): Na2HPO4 13.48 g/l, NaH2PO4 0.78 g/l, NaCl 4.25 g/l 
1x PBS with calcium and magnesium (washing buffer): 100 ml of PBS Ca2+ and 
Mg2+ contains 1mM CaCl2 (0.015g) and 0.5 mM MgCl2 (0.010g) 
Dulbecco’s modified Eagle’s medium (DMEM), high glucose (4.5 g/l), with 1% 
sodium pyruvate and L-glutamine (CatNo. E15-843, PAA Laboratories, Cölbe, 
Germany) 
Newborn calf serum (NCS, CatNo. B11-001, PAA Laboratories, Cölbe, Germany) 
HEPES buffer (N’-2-Hydroxyethylpiperazine-N’-2 ethane sulphonic acid, CatNo. 
S11-001, PAA Laboratories, Cölbe, Germany) 
Dimethylsulfoxid (DMSO, Roth, Karlsruhe, Germany) 
Madin Darby Bovine Kidney cells (MDBK; DSMZ (German Collection of Microorganisms and 
Cell Cultures), Braunschweig, Germany) were used for infection assay and infection inhibition 
assay. 
All used solutions were bought sterile or sterilized by autoclaving or filtration through a cone-
point attachable filter. 
The cells were cultured in 24-well cell culture plate at a density of 1.5-2.0 x105 cells/well to 
obtain a semi-confluent monolayer within 24 h. They were supplied with DMEM high glucose 
medium which was supplemented with 5% NCS, 1% sodium pyruvate and 1% HEPES buffer. 
CFSE-labelled sporozoites of E. tenella were added to semi-confluent monolayers of MDBK 
cells at a ratio of three sporozoites per cell.  
Infected monolayers were incubated at 37°C and 5% CO2. After the infection the cells were 
supplied with growth medium containing a reduced concentration of 2% (v/v) NCS to optimize 
the cell growth and to enhance the infection. The cells were washed twice 24 h post-infection 
(p.i.) using 1x PBS with Ca2+ and Mg2+ followed by supplementation of fresh medium. 
3.6.2  Inhibition assay 
For invasion - inhibition assay, sporozoites were first irreversibly labelled with CFSE. For this 
purpose 1×107 sporozoites were suspended in 2 ml of sterile PBS and 4 µl of a 5 mM solution of 
CFSE was added, resulting in a final concentration of 10 µM.  
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After 10 min of incubation at 37°C, sporozoites were washed twice in DMEM medium or PBS 
supplemented with 5% NCS (to stop reaction). 
Sporozoites were incubated at 37°C with the different purified antibody fragments (10-20 µg/ml) 
for 60 min in 1 ml of growth medium or PBS containing 5% NCS. The sporozoites were rinsed 
twice in PBS by centrifugation at 2,000× g for 5 min. Batches of 105 fluorescent sporozoites 
were used to infect each 105 MDBK cells in a 24-well plate, infected cultures were susequently 
kept at 37°C and 5% CO2. 
After 24 h p.i. the infected cells were washed twice with PBS containing Ca2+ and Mg2+. 
Monolayers were incubated with 100 µl/well AccutaseTM at 37°C for 10-20 min. The detached 
cells of each well were washed twice with 400 µl of culture medium by centrifugation at 7,000 x 
g for 5 min in microfuge tubes.  
The cells were fixed in 1% buffered formaldehyde and were subsequently washed with 1x PBS. 
The fixed cells were kept at 4°C for short time (not exceeding 48 h to avoid changes in size of 
the fixed cells) before analysis in the FACScalibur cytometer at 488 nm for CFSE fluorescence. 
Usually CFSE labelled samples were measured in channel FL1. For each sample, 20,000 events 
were analysed for fluorescent signals using the associated software, Cell Quest ProTM (BD 
Biosciences, Heidelberg, Germany) and visualized in a histogram plot (counts over fluorescence) 
or a density plot.  
All assays were performed in eight replicates and the same conditions were followed. 
3.6.3  Serum samples 
Infected chicken were bled 8-9 days after infection and the blood was allowed to clot at room 
temperature for 2 h. The resulting serum was collected by centrifugation at 3,000 x g for 10 min 
and stored at -20°C until required. Sera of non-infected control chicken were used for 
comparison with those of infected chicken. 
3.6.4  MTT assay (MOSMANN 1983) 
Instrument 
Microplate reader (Anthos Reader 2001, Anthos microsystems GmbH, Krefeld, 
Germany) 
Materials 
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MTT reagent (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; 
Sigma, catalog no. M2128) 
acid-isopropanol (0.04 N HCL in isopropanol) 
Overnight grown MDBK cells (105 cells/well) were exposed to various antibody fragments and 
incubated for 2 h at 37°C and 5% CO2. MTT reagent was added (50 µl/well) and the plates were 
further incubated for 1 h. Precipitated formazan crystals were dissolved by adding acid-
isopropanol. The level of absorption was measured using a microplate reader at 600 nm. 
Experiments were performed in quadruplicate. 
3.7  Antibody neutralization test 
Parasite 
purified sporozoites of Eimeria tenella (see 3.2.3). 
Instruments 
Microscope (CX31, Olympus Optical, Hamburg, Germany) 
Heatable magnetic stirrer (MR3001 K, Heidolph instruments, Schabach, 
Germany) 
Hand-hold blender (MR 305, Braun, Kornberg, Germany) 
Balance (BP310 P, Sartorius AG, Göttingen, Germany) 
Animals and materials 
Anti-Eimeria tenella antibody fragments Ab1, Ab2, Ab3, Ab4, Ab5, Ab6, Ab7, 
Ab8 and Ab9 
Syringe fitted with a rinsing cannula (1.5 x 40 mm) curved with a spherical ball 
tip (Art.Nr. 07505, Wirtschaftsgenossenschaft deutscher Tieraerzte eG, Garbsen , 
Germany) 
Two weeks-old chicken were kept under coccidia free conditions in disinfected 
cages 
McMaster counting chambers (Omnilab-Laborzentrum, Gehrden, Germany) 
Sodium chloride, saturated solution with a specific gravity 1.2 
Graduated plastic cylinder (100 ml, Roth, Karlsruhe, Germany) 
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Small plastic bowl 
Wooden spatula 
Funnel 
Tea strainer 
Glass pasteur pipettes (150 mm, unplugged, Roth, Karlsruhe, Germany) 
Method 
Chicken were divided into 11 groups, 9 in each group, and starved one day before the infection 
to avoid repealing movement of the intestine. Nine groups were infected with treated sporozoites 
(with 9 different antibody fragments). One group was infected with untreated sporozoites as 
positive infected control while one group served as non-infected control. 
Sporozoites of Eimeria tenella were purified by PercollTM gradient (see 3.2.3.4). The sporozoites 
were incubated 1 h at 41°C with the different antibody fragments, then inoculated intracloacally. 
Each chicken was inoculated by a curved canula with 0.25 ml of sporozoites suspension (2 x 104 
sporozoites) into the right or left cecum. 
After the infection the chicken were given feed and water ad libitum. The oocyst count (oocysts 
per gram, OPG) was performed over a period of 5 days starting on the 7th day post-infection.  
4 g of faeces were suspended in about 15 ml saturated salt solution. The suspension was passed 
through a funnel and tea strainer into a 100 ml plastic graduated cylinder. The volume of the 
suspension was increased with saturated salt solution to 60 ml. A magnetic rod was added and 
the suspension was mixed with a magnetic stirrer for 2 min at the highest setting. 
From the central vortex 1 ml was removed with a pipette and transferred into two chambers of a 
McMaster slide, ensuring that no air bubbles form. The slides were left on the side-bench for 2 
min to allow floatation of the oocysts. The slides were examined microscopically at a 
magnification of x100. The mean number of oocysts counted in the scaled areas of both 
champers multiplied by 100 is the oocyst count per gram of faeces. 
The results were recorded and interpreted in comparison with a positive control group. 
3.8  Statistical analysis 
Data analysis was performed using GraphPad prism Software Inc. (GraphPad , 2236 Avenida de 
la Playa La Jolla, CA 92037 USA). The ANOVA one-way test was used to test for differences 
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between the treatments. The data were expressed as mean +/- SEM (Standard error of the mean). 
The Bonferroni’s Multiple Comparison Test was used to determine the significance of 
differences between the mean values of the treatments. The results were considered significant 
when the probability (P) value was less than 0.05 (P < 0.05). 
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4       Results 
4.1  Single oocyst infection (SOI) 
Regarding Eimeria maxima oocyst shedding was evident only in 4 of 15 chicken infected with a 
single oocyst and an average of 9,450 oocysts was excreted per positive chicken. These oocysts 
were used to infect 10 chicken with an infection dose of 2,000 oocysts per chicken and finally 5 
x106 oocysts / chicken were collected and purified in a period of 5 days. 
In case of E. tenella SOI 32,000 oocysts were obtained from one chicken out of 10 chicken at the 
7th day post infection. Altogether 106 oocysts / chicken were collected during the next passage. 
Following E. acervulina SOI 25,000 oocysts were collected from one out of 10 chicken. Oocyst 
excretion was recorded at the 5th day post infection. During the succeeding passage, an average 
of 3 x 106 oocysts / chicken was collected. 
In case of E. brunetti after SOI the oocyst excretion was recorded only in one out of 15 chicken 
and the oocyst output was 8,500 oocysts. During the succeeding passage, shedding was recorded 
at the 7th day post infection with an average of 5 x 106 oocysts / chicken (Table 4.1). 
Table 4.1: Oocyst shedding after single-oocyst-infection (SOI) and subsequent passage. 
Oocyst output/chicken  
(in a period of 5 days) 
 
Species 
Prepatency (in days) 
SOI Passage  
E. tenella 6-7  32 x 103 106 
E. maxima 6-8  9.5 x 103 5 x 106 
E. acervulina  4-6  2.5 x 103 3 x 106 
E. brunetti  6-8  8.5 x 103 5 x 106 
 
The obtained oocysts were checked by PCR for homogenicity of the respective Eimeria spp. The 
PCR performed on DNA samples from the single oocyst infection suggested the presence of only 
one Eimeria spp. in the infected animals, as no amplification of DNA of other Eimeria spp. was 
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observed. The corresponding bands of 303, 395, 151, and 463 bp in case of E. acervulina, E. 
brunetti, E. maxima, and E. tenella, respectively, were clearly visible (Figure 4.1). 
 
Figure 4.1: PCR products obtained after amplification of DNA from Eimeria oocysts after SOI. 
M: marker with bands from 100 to 3000 base pairs; 1: amplification of DNA from oocysts after 
SOI corresponding to E. acervulina (303 bp), E. brunetti (395 bp), E. maxima (151 bp) and E. 
tenella (463 bp); 2: positive control; and 3: negative control (amplification from H2O). 
 
However, these pure species became contaminated with other Eimeria spp. during the 
subsequent passage. The PCR led to slight amplification of E. acervulina DNA (303 bp), 
suggesting the presence of at least few oocysts of E. acervulina after passage of SOI generated 
E. tenella, E. brunetti and E. maxima. 
4.2  Purification of sporozoites and merozoites of Eimeria spp.  
Sporozoites of E. tenella were purified by two PercollTM density gradients. Firstly the sporocysts 
were purified after glass-bead grinding and 80% of undamaged sporocysts were recovered. The 
second PercollTM gradient purification was used after the excystation of the sporozoites and 
resulted in 90% recovery of the sporozoites loaded onto the gradient while only 70% of the 
sporozoites loaded onto DE-52 column chromatography were recovered. The sporozoites 
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recovered from PercollTM density gradients and DE-52 column chromatography were 95% pure 
with final recovery of about 2-3 sporozoites per oocyst. 
The sporozoites of E. acervulina, E. maxima, and E. brunetti were purified by DE-52 column 
chromatography and only 70% were recovered from those loaded onto the gradient with a purity 
degree of 90%. 
The merozoites of Eimeria spp. were purified only by DE-52 column chromatography with a 
high degree of purity of 90%. Merozoites were directly fixed on slides for indirect 
immunofluorescence or were frozen in liquid nitrogen for later use. 
4.3  Indirect fluorescent antibody test (IFAT) 
Due to the high degree of conservation of calmodulin-domain protein kinases (CDPK) in 
Eimeria spp. the rabbit anti-Eimeria bovis-calmodulin domain protein kinase-antiserum (Anti-
EbCDPK) was used undiluted as positive control. The control antiserum showed strong 
fluorescence reaction with methanol fixed and buffered formaldehyde fixed sporozoites and 
merozoites of E. tenella, E. maxima, E. acervulina, and E. brunetti. The fluorescence was 
observed on the surface of all sporozoites and merozoites (Figure 4.3.1). 
 
 
Figure 4.3.1: Reaction of Anti-EbCDPK with Eimeria spp. sporozoites (A) and merozoites (B), 
the reaction is located on surface of both merozoites and sporozoites. The zoites were fixed with 
methanol and buffered formaldehyde (x100 magnification) 
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Antibody binding to parasitic stages was detected using undiluted and 1:10 diluted antibody 
fragments but no reaction was observed using 1:100 and 1:1000 diluted antibodies. The 
concentration of antibodies was measured by Bradford assay and ranged from 0.3 µg/µl to 5.5 
µg/µl (Table 4.3.1). 
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Table 4.3.1: Concentrations of different antibody fragments measured by Bradford technique 
Antibody fragments Concentration in ng/µl (µg/ml) 
Ab1 4.0 
Ab2 5.4 
Ab3 5.4 
Ab4 0.3 
Ab5 5.4 
Ab6 5.7 
Ab7 1.6 
Ab8 5.5 
Ab9 4.7 
Seven of nine antibody fragments (Ab1, Ab4, Ab5, Ab6, Ab7, Ab8 and Ab9) showed positive 
reaction with E. tenella sporozoites (Table 4.3.2 and Figure 4.3.2). Two Ab fragments (Ab4 and 
Ab5) showed cross reactivity with sporozoites of E. brunetti, E. acervulina and E. maxima 
(Table 4.3.2 and Figure 4.3.3). In contrast, Ab2 and Ab3 showed no binding to any zoites 
(sporozoites and merozoites) of Eimeria species.  
 
Table 4.3.2: Cross reactivity of anti-Eimeria tenella-antibody fragments with  
 sporozoites and merozoites of chicken Eimeria species. 
Antibody 
fragments  
Ab1 Ab2 Ab3 Ab4 Ab5 Ab6 Ab7 Ab8 Ab9 
sporozoites + - - + + + + + + 
E. tenella 
merozoites - - - - - - - - - 
sporozoites - - - + + - - - - 
E. brunetti 
merozoites - - - - - - - - - 
sporozoites - - - + + - - - - 
E. acervulina 
merozoites - - - - - - - - - 
sporozoites - - - + + - - - - 
E. maxima 
merozoites - - - - - - - - - 
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The localization of specific fluorescence on sporozoites varied between species. No specific 
antibody binding could be observed on merozoites of all examined Eimeria species. 
In case of Ab4 and Ab5 some differences in localization of binding could be distinguished 
among sporozoites of different Eimeria species. Ab4 and Ab5 binding with sporozoites was seen 
in both anterior and posterior refractile bodies in case of E. tenella, E. brunetti and E. maxima 
but was only observed in the posterior refractile body in case of E. acervulina (Figure 4.3.4). 
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Figure 4.3.2: Reaction of sporozoites of E. tenella with Ab1 (A), Ab4 (B), Ab5 (C), Ab6 (D), 
Ab7 (E), Ab8 (F) and Ab5 (G). Ab binding was visualized by green fluorescence (FITC), blue 
fluroscence (DAPI) and red fluroscence (Evans Blue). The latter is the counterstain for 
visualising the position of refractile bodies (x100 magnification) 
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Figure 4.3.3: Reaction of sporozoites of Eimeria spp. with Ab4 and Ab5. A and B represent Ab 
reaction with sporozoites of E. brunetti, C and D with sporozoites of E. acervulina and E and F 
with sporozoites of E. maxima. Ab binding was visualized by green fluorescence (FITC), blue 
fluroscence (DAPI) and red fluroscence (Evans Blue) as counterstain to visualise the position of 
refractile bodies (x100 magnification) 
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Figure 4.3.4: Ab4 and Ab5 binding reaction with sporozoites of Eimeria spp. was localized in 
the cytoplasm in the area of both anterior and posterior refractile bodies in case of E. tenella (A, 
B, respectively), E. brunetti (C, D, respectively) and E. maxima (G, H, respectively) but was 
only observed in the cytoplasm of the posterior refractile body in case of E. acervulina (E, F, 
respectively). (x100 magnification) 
Results 
 
 
56 
 
4.4  Invasion inhibition assay 
According to the results of indirect immunofluorescence analysis most (seven of nine) of tested 
antibody fragments showed binding ability to E. tenella sporozoites more than to other species. 
Thus only E. tenella sporozoites were used in both in vivo and in vitro assays.  
The infected MDBK cells were treated with trypan blue (0.2% solution) to quench the 
fluorescence of the extracellular and attached parasites and to distinguish them from the invading 
intracellular sporozoites. However, there were no remarkable differences observed between the 
trypan blue treated and non-treated cells. The CFSE labelled sporozoites were exposed to trypan 
blue (0.2% solution) and observed microscopically for 3-5 min and the fluorescence emission 
was properly quenched. Washing of infected cells twice with PBS containing Ca+2 and Mg+2 24 
h after the infection with labelled sporozoites was sufficient to remove attached and dead 
sporozoites away from the host cell monolayers. 
The main population of non-infected host cells were detected by FC analysis in the upper R2 
region while infected cells (fluorophore containing labeled sporozoites) were placed in the upper 
R3 region. The non-labeled sporozoites were located in the lower R2 region and the labeled ones 
were in the lower R3 region. Such differences in size and fluorescence content between the 
different cell types could be easily determined by FC analysis. Therefore the infected cells could 
be reliably distinguished from the non-infected cells and from the extracellular sporozoites 
(Figure 4.4). 
The invasion rates of E. tenella sporozoites were determined by FC analysis following 24 h of 
incubation of the MDBK cells with the treated sporozoites at 37°C and 5% CO2. 
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Figure 4.4: Analysis of different cell types by FC analysis; upper R2 represents the main 
population of non-infected host cells, upper R3 represents the infected host cells (containing 
labeled sporozoites), lower R2 represents the non-labeled sporozoites and lower R3 represents 
the labeled sporozoites. 
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4.4.1  Invasion inhibition after treatment with antibody fragments 
Treatment of sporozoites with Ab3, Ab6 and Ab7 led to reduction of invasion rates by 35%, 
44.8% and 39.8%, respectively, compared to invasion rates of untreated sporozoites. Ab1, Ab2, 
Ab4, Ab5, Ab8 and Ab9 reduced the invasion rates less by 29.6%, 30.3%, 23.8%, 31.7%, 30.2%, 
and 32.4%, respectively (Table 4.4.1 and Figure 4.4.1). 
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Figure 4.4.1: Comparison between invasion rates of control group of MDBK cells infected with 
untreated E. tenella sporozoites or sporozoites treated with antibody fragments (Ab1, Ab2, Ab3, 
Ab4, Ab5, Ab6, Ab7, Ab8 and Ab9). The numbers of infected MDBK cells are the mean +/- 
SEM values of two experiments done in 8 replicates and determined by FC analysis. All cells 
were incubated for 24 h after the infection at 37°C and 5% CO2. 
* The mean difference is statistically significant at the P value of < 0.05 level compared to 
untreated control. 
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Table 4.4.1: Invasion rates and invasion inhibition rates of E. tenella sporozoites1, as determined 
by FC analysis after 24 h incubation of MDBK cells with sporozoites incubated with different 
antibody fragments.  
Treatment Mean of invasion %1 Invasion rate %2 Invasion inhibition %3 
Untreated control 37.3 100 0.0 
Ab 1 26.2* 70.4 29.6* 
Ab 2 26.0* 69.7 30.3* 
Ab 3 24.2* 64.8 35.2* 
Ab 4 28.4* 76.2 23.8* 
Ab 5 25.5* 69.3 31.7* 
Ab 6 20.6* 55.2 44.8* 
Ab 7 22.4* 60.2 39.8* 
Ab 8 26.0* 69.8 30.2* 
Ab 9 25.2* 67.6 32.4* 
* The mean differs statistically significant at the P = 0.05 level compared to untreated control 
1All results are the mean of two experiments with 8 replicates for each treatment. 
2Invasion rate%= invasion % of Ab treated / invasion % of untreated control 
3Invasion inhibition rate = invasion rate % of untreated control - invasion rate % of sporozoites incubated with 
antibody fragment. 
 
4.4.2  Invasion inhibition rates after incubation with mixed antibody fragments 
Simultaneous incubation of sporozoites of E. tenella with all antibody fragments in dilutions of 
1:1000 resulted in no reduction of invasion rate. In contrast, invasion was inhibited by 9% and 
10.9% after incubation with dilutions of 1:100 and 1:10, respectively. Application of undiluted 
antibody fragments had the most pronounced effect with 21.8% reduction of invasion. 
Statistically significant results were observed between treated and non treated groups at the level 
of P value < 0.05 (Table 4.4.2 and Figure 4.4.2). 
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Table 4.4.2: Invasion rates and invasion inhibition rates of E. tenella sporozoites1, determined 
by FC after 24 h incubation of MDBK cells with sporozoites treated with different dilutions of 
mixed antibody fragments 
 Untreated 
control 
Undiluted Ab 
mixture 
1:10 diluted 
Ab mixture 
1:100 diluted 
Ab mixture 
1:1000 diluted 
Ab mixture 
Invasion %1 37.7 29.5* 33.6* 34.3* 37.7 
Invasion rate%2 100 78.2 89.1 91 100 
Invasion inhibition 
rate 3 0.0 21.8* 10.9* 9.0* 0.0 
* The mean difference is statistically significant at the P = 0.05 level compared with untreated control. 
1All results are the mean of two experiments with 8 replicates for each treatment. 
2Invasion rate%= invasion % of Ab treated / invasion % of untreated control 
3Invasion inhibition rate = invasion rate % of untreated control - invasion rate % of Ab treated. 
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Figure 4.4.2: Comparison of infection rates of MDBK cells after incubation with untreated E. 
tenella sporozoites or of sporozoites treated with undiluted or diluted (1:10, 1:100 and 1:1000) 
mixture of all antibody fragments (Abs). The numbers of infected MDBK cells are the mean +/- 
SEM values of two experiments and 8 replicates as determined by FC analysis. All cells were 
incubated for 24 h after the infection at 37°C and 5% CO2. 
* The mean difference is statistically significant at the P value of < 0.05 level compared to 
untreated control. 
 
4.4.3  Invasion inhibition after treatment of sporozoites with chicken immune sera 
Sera of non-infected chicken and of E. tenella infected chicken were collected 7 days post 
infection and used to compare their inhibitory effect to the effect of antibody fragments on 
invasion of E. tenella sporozoites. 
The invasion rates were reduced to 39.7%, 20.4%, and 68.6% in case of host cells infected with 
E. tenella sporozoites treated with 1:100, 1:10, or undiluted serum of E. tenella infected chicken, 
respectively. Treatment of sporozoites with 1:100, 1:10, or undiluted serum of non-infected 
chicken resulted in reduction of invasion rates to 32.2%, 33.9%, and 69.9%, respectively. In case 
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of host cells infected with sporozoites treated with 1:100, 1:10, and undiluted Anti-EbCDPK, the 
invasion inhibition rates were 15.8%, 42.7%, and 63.7%, respectively (Table 4.4.3 and Figure 
4.4.3). 
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Figure 4.4.3: Comparison between infection rates of MDBK cells. Cells were infected with 
sporozoites treated with undiluted, 1:10, and 1:100 diluted sera or with polyclonal anti-EbCDPK 
antibody. Sera originated from non-infected chicken (S-non inf.) and from E. tenella infected 
chicken (Et-S). Positive controls were infected with untreated E. tenella sporozoites. The values 
represent the mean values of 8 replicates as determined by FC analysis. All cells were incubated 
for 24 h after the infection at 37°C and 5% CO2.  
*The mean difference is statistically significant at the P value of < 0.05 level compared to 
untreated control. 
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Table 4.4.3: Invasion rates of E. tenella sporozoites1, as determined by FC after 24 h incubation 
of MDBK cells
 
with sporozoites treated with different dilutions of sera originating from non 
infected or infected chicken with E. tenella.  
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Invasion %1 12.4 3.9* 9.9* 7.5* 3.7* 8.2* 8.4* 4.5* 7.1* 10.4* 
Invasion rate %2 100 31.4 79.6 60.3 30.1 66.1 67.8 36.3 57.3 84.2 
Invasion 
inhibition %3 0 68.6* 20.4* 39.7* 69.9* 33.9* 32.2* 63.7* 42.7* 15.8* 
* The mean difference is statistically significant at the P value of < 0.05 level compared with untreated control 
1All results are the mean of two experiments with 8 replicates for each treatment. 
2Invasion rate%= invasion % of Ab treated / invasion % of untreated control 
3Invasion inhibition rate = invasion rate % of untreated control - invasion rate % of sporozoites incubated with 
antibody fragments. 
 
4.5  Proliferation rates of the host cells under different treatments 
The detrimental effects of antibody fragments on the proliferation rates (PR) and the viability of 
MDBK cells were studied by FC analysis and MTT. All results are the mean of two experiments 
with 8 replicates for each treatment. 
4.5.1  PR after treatment with single antibody fragments 
As determined by FC assays and MTT assay, PR of host cells were reduced after application of 
Ab preparations. This reduction paralleled the reduction in the invasion rates of host cells. PR of 
MDBK cells incubated with Ab2 and Ab4 were highly reduced by 23.0% and 26.0%, 
respectively, with reduction in invasion rates by 30.3% and 23.8%, respectively. In contrast, PR 
of MDBK cells incubated with Ab1, Ab3, Ab5, Ab6, Ab7, Ab8 and Ab9 were moderately 
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reduced by 19.5%, 18.0%, 17.0%; 17.5%, 19.5%, 17.5% and 15.0%, respectively, with invasion 
rates reduced by 29.6%, 35.2%, 31.7%, 44.8%, 39.8%, 30.2% and 32.4%, respectively (Table 
4.5.1 and Figure 4.5.1).  
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Figure 4.5.1: Comparison between proliferation rate (PR) and invasion rates of MDBK cells. 
MDBK cells were infected with E. tenella sporozoites treated with undiluted antibody fragments 
(Ab1, Ab2, Ab3, Ab4, Ab5, Ab6, Ab7, Ab8, and Ab9). Controls were infected with untreated E. 
tenella sporozoites PR values are the mean of two measurements; FC and MTT, with 8 replicates 
for each treatment. 
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Table 4.5.1: Proliferation rates (PR) 1 of host cells incubated with different antibody fragments 
as measured by FC2 and MTT3  
 PR % 
  FC2 % MTT3% Mean 
Reduction 
in PR % 
Invasion 
inhibition%4 
Untreated control  100.0 100.0 100.0 0.0 0.0 
Ab 1 81.0 80.0 80.5 19.5 29.6* 
Ab 2 73.0 81.0 77.0 23.0 30.3* 
Ab 3 81.0 83.0 82.0 18.0 35.2* 
Ab 4 62.0 86.0 74.0 26.0 23.8* 
Ab 5 76.0 90.0 83.0 17.0 31.7* 
Ab 6 80.0 85.0 82.5 17.5 44.8* 
Ab 7 75.0 86.0 80.5 19.5 39.8* 
Ab 8 80.0 85.0 82.5 17.5 30.2* 
Ab 9 82.0 88.0 85.0 15.0 32.4* 
* The mean differs statistically significant at the P < 0.05 level compared to untreated control. 
1All results are the mean of two experiments with 8 replicates for each treatment. 
2
 Cells were incubated 24 h, at 37°C, 5% CO2. 
3Cells were incubated at 37°C, 5% CO2 for 4 h during treatment, 3h with MTT-reagent and PR of the cells were 
measured by microplate ELISA reader. 
4Invasion inhibition rate = invasion rate % of untreated control - invasion rate % of sporozoites incubated with 
antibody fragment. 
 
4.5.2  PR after treatment with different dilutions of mixed antibody fragments 
PR of host cells treated with 1:1000, 1:100, 1:10 and undiluted mixed antibody fragments were 
reduced by 1%, 10%, 16%, and 26%, respectively, with a reduction in invasion rates by 0%, 9%, 
15% and 18%, respectively. This reduction in PR is proportionally correlated to the 
concentration of the mixed antibodies and to the invasion inhibition rates of host cells treated 
with the same dilutions. Such results suggest the presence of toxic components in the 
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preparations of these antibody fragments which may affect the viability and proliferation of 
MDBK cells (Table 4.5.2 and Figure 4.5.2). 
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Figure 4.5.2: Comparison between proliferation rate (PR) and invasion rates of MDBK cells. 
MDBK cells were infected with E. tenella sporozoites treated with undiluted, 1:10, 1:100, and 
1:1000 diluted mixtures of all antibody fragments (Abs). Controls were infected with untreated 
E. tenella sporozoites. PR values and invasion rates are the mean of two measurements with 8 
replicates for each treatment. 
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Table 4.5.2: Reduction in invasion rates1 and proliferation rates (PR) 2 of MDBK treated with 
different dilutions of mixed antibody fragments 
  
Infection 
rate 
Invasion 
inhibition % PR 
Reduction 
in PR 
untreated control 100% 0% 100% 0% 
undiluted Abs 82% 18% 74% 26% 
1-10 Abs 85% 15% 84% 16% 
1-100 Abs 91% 9% 90% 10% 
1-1000 Abs 100% 0% 99% 1% 
1Invasion inhibition rate = invasion rate % of untreated control - invasion rate % of sporozoites incubated with 
antibody fragments. 
2
 PR are the mean of two experiments, FC and MTT assay, with 8 replicates for each treatment. 
 
4.5.3  PR after incubation of MDBK with sporozoites treated with serum 
Reduction in the PR of host cells ranged from 2% to 11% when sporozoites were treated with 
sera in different dilutions (see Table 4.5.3). However, the sera favoured the proliferation of the 
host cells as demonstrated by application of heat inactivated serum (data not shown). Invasion 
rates of host cells ranged from 69.9% to 15.8% (see Table 4.5.3 and Figure 4.5.3) in comparison 
to the untreated host cells. 
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Table 4.5.3: Proliferation rates (PR) 1 of host cells incubated with sporozoites pre-incubated with 
different dilutions of serum or with Anti-EbCDPK  
 
Invasion 
inhibition %2 
PR 
% 
Reduction 
in PR % 
untreated control 0.0 100 0 
Serum of E. tenella infected chicken (undiluted) 68.6 108 0 
Serum of E. tenella infected chicken (1:10 diluted) 20.4 104 0 
Serum of E. tenella infected chicken (1:100 diluted) 39.7 91 9 
Serum of non-infected chicken. (undiluted) 69.9 98 2 
Serum of non-infected chicken (1:10 diluted) 33.9 90 10 
Serum of non-infected chicken (1:100 diluted) 32.2 97 3 
Anti-EbCDPK (undiluted) 63.7 114 0 
Anti-EbCDPK (1:10 diluted) 42.7 110 0 
Anti-EbCDPK (1:100 diluted) 15.8 89 11 
1All results are the mean of two measurements; FC and MTT assay, with 8 replicates for each treatment. 
2Invasion inhibition rate = invasion rate % of untreated control - invasion rate % of sporozoites incubated with 
antibody fragment. 
 
Invasion rates were moderately reduced in host cells incubated with sporozoites treated with 
antibody fragments, however, the proliferation rates of the host cells were greatly affected under 
these treatments. While the PR values of MDBK cells infected with sporozoites treated with sera 
were not affected, sera reduced the invasion rates more than the tested antibody fragments and 
favoured the proliferation rates of the host cells. 
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Figure 4.5.3: Comparison between proliferation rate (PR) and invasion rates of MDBK cells. 
MDBK cells were infected with E. tenella sporozoites treated with different dilutions (undiluted, 
1:10, and 1:100) of sera of non-infected (S.non-inf) or infected chicken (Et-S) or with Anti-
EbCDPK. Controls were infected with untreated E. tenella sporozoites. PR values are the mean 
of two measurements; FC and MTT assay were performed with 8 replicates for each treatment. 
 
4.6  In vivo antibody neutralization test  
The purified sporozoites of E. tenella were pre-incubated for one hour at 37°C with the different 
antibody fragments in a concentration of 1:10. The sporozoite suspension was inoculated 
intracloacally to avoid effects of digestive enzymes on the antibodies.  
During the preliminary trials it was noticed that the sporozoite inoculum was sometimes repealed 
out with the faeces directly after inoculation. Withholding of feed and water for several hours 
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before the inoculation appeared suitable to enhance evacuation of the rectum. There was no 
record of any mortality within the infected chicken during this experiment. 
The control group was infected intracloacally with untreated E. tenella sporozoites. The oocyst 
output (OPG) was markedly reduced in case of chicken infected with sporozoites treated with 
antibody fragments Ab1, Ab3, Ab5, and Ab9 (Table 4.6 and Figure 4.6.1).  
OPG was moderately to slightly reduced in case of chicken infected with sporozoites pre-treated 
with Ab6 and Ab8 in comparison to the control group Statistically, the mean differences were 
found significant at the P value < 0.05 level in case of Ab1, Ab3, Ab5 and Ab8 (Table 4.6 and 
Figure 4.6.2).  
 
Table 4.6: Reduction in oocyst excretion one week after intracloacal inoculation of sporozoites 
treated with antibody fragments 
% of OPG reduction2  
dpi1 
Untreated 
control 
OPG Ab1* Ab2 Ab3* Ab4 Ab5* Ab6 Ab7 Ab8* Ab9 
7 139325 93 0 76 51 98 84 63 15 80 
8 63025 64 16 74 0 99 38 0 64 89 
9 79500 52 59 90 55 89 54 52 70 85 
10 74250 83 73 58 66 87 74 54 58 89 
11 26500 70 43 0 21 96 0 8 0 68 
12 17550 67 30 29 7 96 57 11 23 66 
O
PG
 
13 18550 78 62 73 19 100 68 78 27 68 
1dpi is days post-infection. 
2 % of OPG reduction = % of OPG of untreated control - % of OPG of Ab treated group. 
* The mean of total OPG over observation period differs statistically significant at the P < 0.05 level 
compared to untreated control 
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Figure 4.6.1: OPG of chicken infected intracloacally with E. tenella sporozoites. E. tenella 
sporozoites were treated with Ab1, Ab3, Ab5, Ab7, or Ab9, respectively. The mean differences 
of total oocyst output over observation period were found statistically significant as compared to 
the untreated control at the P value < 0.05 level in case of Ab1, Ab3, Ab5 and Ab8. 
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Figure 4.6.2: OPG of chicken infected intracloacally with E. tenella sporozoites. E. tenella 
sporozoites were treated with Ab2, Ab4, Ab6, Ab7, or Ab8, respectively. The mean differences 
of total oocyst output over observation period were found statistically significant as compared to 
the untreated control at the P value < 0.05 level in case of Ab1, Ab3, Ab5 and Ab8.
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5       Discussion 
Poultry coccidiosis is caused by infection with Eimeria spp. This disease has great economic 
impact on poultry production particularly in intensively reared commercial flocks (WALLACH 
et al. 1995; LILLEHOJ and LILLEHOJ 2000). The disease is associated with the enteric 
predilection site of the parasites. Clinical signs include decreased feed conversion efficiency, 
decreased growth rate, diarrhoea, dehydration and possibly mortality (BARKER 1993). The cost 
of coccidiosis to the poultry industry is high due to decreased food utilization and weight gain 
and to costs of prophylactic and therapeutic drug use to control infection with estimated annual 
costs of $800 million (DANFORTH 1986; WILLIAMS 1998). 
In intensive poultry farms, the incidence of clinical disease is generally low despite the crowding 
of the animals. This is due mainly to the proper application of prophylactic anticoccidial drugs 
(SHIRLEY and BEDRNIK 1997). However, with the increased prevalence of drug resistant 
parasites, there is increasing interest in vaccines and recombinant antibodies (SHIRLEY et al. 
2005). Success of vaccination is based on the fact that once a bird has been infected it develops 
protective immunity against the respective Eimeria species (LILLEHOJ and LILLEHOJ 2000). 
Some antibodies with inhibitory effect on various Eimeria-stages have already been identified 
(DANFORTH et al. 1985; LILLEHOJ and CHOI 1998; LABBE et al. 2005). Such antibodies 
produced in plants used for animal feeding could offer a simple and inexpensive 
biopharmaceutical means for coccidiosis control. Plant based antibodies (plantibodies) are 
supposed as alternative options to control several animal diseases, for example: Foot-and-Mouth-
Disease (SANTOS et al. 2005), Rinderpest (KHANDELWAL et al. 2003a; KHANDELWAL et 
al. 2003b), rotavirus infection (SALDANA et al. 2006) and infectious bronchitis virus (IBV) 
(ZHOU et al. 2003). Plant-based recombinant chicken sIgA was expressed in tobacco leaves and 
induced immune protection against coccidiosis (WIELAND et al. 2006). 
There are several potential advantages of using plant technology for the production of vaccines; 
most notably, the overall costs can be greatly reduced compared with competing systems. This is 
mainly due to the relatively low cost afforded by oral delivery of antigen in large amounts. 
Despite the obvious advantages of plant-based vaccines there are still severe biosafety 
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limitations as well as concerns in the public to genetically modified plants. With increased public 
awareness of biotechnology, especially plant genetics, companies working in this field will have 
to supply sufficient appropriate information to the public and other interested stakeholders. 
Currently, transgenic crops are planted on very small acreages with the intent of developing high 
expressing plant lines and generating material for experimental trials. Thus, much of the material 
generated for this purpose is grown in contained greenhouses. Application intended to open-field 
cultivation might evoke potential risks that must be assessed case-by-case. Potential biosafety 
risks are transgene spread in the environment, recombinant protein accumulation in the 
ecosystem, contamination of food and feed chains with transgenes and their products. Also 
product quality and safety are discussed (COMMANDEUR et al. 2003). However, these 
potential risks can be controlled by various physical and biological means (COMMANDEUR et 
al. 2003). 
Different attempts have been made to immunize chicken against coccidiosis throughout the 
world by using different antigenic materials including low doses of sporulated oocysts (EDGAR 
1958), irradiated sporulated oocysts (REHMAN 1971), sporozoites (GARG et al. 1999), 
merozoites, recombinant merozoite antigen (JENKINS 1998) recombinant refractile body 
antigen (KOPKO et al. 2000) and inactivated sporulated oocysts (AKHTAR et al. 2001). None 
of these experimental vaccines reached the commercial scale. Later, vaccines from virulent or 
attenuated strains were developed and are being marketed now in different countries (LEE 1987; 
SHIRLEY 1989; BEDRNIK 1996). Recently, a subunit vaccine against coccidiosis (CoxAbic®) 
which contains recombinant antigens expressed in bacteria has been commercialized (BELLI et 
al. 2004). 
The aim of the present study is to evaluate the inhibitory effect of some recombinant antibody 
fragments against Eimeria tenella which have been expressed in a transgenic pea plant. If 
efficacious, these antibody fragments might be implemented later as a food constituent to protect 
chicken from infection with coccidia. Both in vitro and in vivo infection experiments were 
performed to evaluate the inhibitory effect of these antibody fragments on E. tenella by indirect 
immunofluorescence test, flow cytometry and in vivo antibody neutralisation assay. 
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The future use of these plantibodies is mainly to stop coccidiosis or minimize its severity, and 
thereby to increase food gain conversion rate, to decrease mortality and to save economic losses. 
Alternatives to anticoccidials are potentially attractive to owners of poultry farms because of 
their low costs and the gradual loss of anticoccidial drug efficacy due to increasing resistance 
(ALLEN and FETTERER 2002; KITANDU and JURANOVA 2006). It would be a significant 
step forwards to find an alternative, drug free, and economic method to control coccidiosis by 
using feeding plants expressing protective antibody fragments such as pea, corn or soya bean. 
A simple method of single oocyst infection has been successfully applied to produce 
homogenous Eimeria isolates representing a single species from field samples, that contain 
mixed Eimeria spp. in most cases (JOYNER and NORTON 1983). The species specific 
polymerase chain reaction with different protocols (SCHNITZLER et al. 1998; SCHNITZLER et 
al. 1999; SU et al. 2003) was used as a supplementation to the classical parasitological methods, 
which are based on parasite morphology, intestinal lesions and prepatent periods, to identify the 
respective Eimeria species (CHAPMAN 1982). The species-specific PCR was optimized and 
successfully established as a laboratory test to differentiate oocysts and to confirm purity of 
laboratory strains.  
Unfortunately, after single oocyst infection the number of obtained oocysts was insufficient for 
further experimental procedures. The next passages which were done to propagate the few 
obtained oocysts of a single species led to contamination by other Eimeria species. Maintaining 
the purity of Eimeria species under the given conditions appeared impossible. The chicken 
should be reared in positive air pressure isolators supplied with HEPA (high-efficiency 
particulate air) filtered air to prevent contamination (SHIRLEY and HARVEY 1996; 
JORGENSEN et al. 1997). Such stringent pathogen free conditions were not available. The 
production and maintenance of pure strains would enable evaluation of antibodies against 
specific Eimeria species and assessment of immunogenicity to each individual species or strain. 
The slight DNA amplification bands of other Eimeria species (mostly E. acervulina) suggested 
the presence of only few contaminating oocysts, as PCR is very sensitive giving a positive signal 
from as little as 10 oocysts (SCHNITZLER et al. 1998; SCHNITZLER et al. 1999; SU et al. 
2003). Because microscopical examination indicated morphological homogenicity of oocysts 
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and the respective target DNA was strongly amplified (see results, Figure 4.1), contamination 
was regarded not significant for the current study. 
An advantage of PCR diagnosis is the high sensitivity and specificity which makes it possible to 
diagnose different Eimeria species present in the same samples (SCHNITZLER et al. 1998; 
SCHNITZLER et al. 1999; ALLEN and FETTERER 2002; SU et al. 2003; MORRIS and 
GASSER 2006). However, conventional PCR lacks the option to exactly quantify the number of 
Eimeria oocysts.  
A sensitive assay capable to identify, differentiate and quantify the Eimeria spp. present in 
chicken with mixed infection or to precisely determine the degree of purity or contamination in 
single oocyst isolates would be highly desirable. Recently a real-time PCR assay has been 
published (MORGAN et al. 2009) which will help to screen the purity of isolates.  
Nine antibody fragments were screened in the current study by indirect immunofluorescent 
antibody test for the binding reactivity with sporozoites and merozoites of various Eimeria 
species. Only 7 of 9 antibody fragments were binding to sporozoites of E. tenella. Of these 7 
antibody fragments only two (Ab4 and Ab5) displayed cross reactivity with the sporozoites of E. 
brunetti, E. maxima, and E. acervulina. None of these antibodies showed a binding reactivity 
with the merozoites of any of the above mentioned Eimeria species. Ab2 and Ab3 showed no 
binding to any zoites of Eimeria spp. 
Failure of immunofluorescent staining of merozoites of different Eimeria species is suggesting 
that the target antigens used for preparation of these antibody fragments are not expressed on 
merozoites owing to different antigen patterns of merozoites and sporozoites of Eimeria spp. 
These differences were also evident between sporozoites and merozoites of Eimeria spp. 
(REDUKER and SPEER 1986) and 29 SAGs (surface antigen genes) of E. tenella were 
expressed solely by merozoites but not by sporozoites (TABARES et al. 2004). Sporozoites and 
second generation merozoites of E. tenella varied in reaction location with the immune 
monoclonal antibody 13.90 (SPEER et al. 1989). Merozoites and sporozoites of Eimeria spp. are 
different in their ultrastructures as the refractile bodies are not found in the first generation 
merozoites and are replaced by several smaller spherical bodies (HAMMOND et al. 1970; 
DANFORTH and AUGUSTINE 1989). Antigens unique to sporozoites or merozoites may 
Discussion 
 
 
77 
 
represent stage-specific differentiation, as has been reported in T. gondii (KASPER et al. 1984; 
KASPER and WARE 1985) and Plasmodium spp. (TOURE-BALDE et al. 2009). 
Fluorescence was observed on the outer surface of the sporozoites of Eimeria tenella for Ab1, 
Ab6, Ab7, Ab8 and Ab9 and thus these antibody fragments are obviously reacting with surface 
antigen. In contrast, the binding reaction of Ab4 and Ab5 was located in the posterior and 
anterior refractile bodies in case of E. tenella, E. brunetti and E. maxima but was only observed 
in association to the posterior refractile body in case of E. acervulina. 
Cross-reactivity of Ab4 and Ab5 was observed with sporozoites of E. acervulina, E. brunetti and 
E. maxima. This indicates the presence of common antigen. (DANFORTH and AUGUSTINE 
1983) also reported cross-reactivity of immune serum from birds infected with different Eimeria 
species. The candidate antigen used for production of the antibody fragments in the present study 
is presumably conserved in E. acervulina, E. brunetti and E. maxima; however this assumption 
deserves further investigations. 
The immunofluorescent staining of sporozoites of E. acervulina, E. maxima and E. brunetti with 
most of the tested antibody fragments was unsuccessful showing that antigenicity varies between 
species. It is well known that immunity to E. tenella does not confer resistance to E. maxima or 
other species (MCDOUGALD 2008) and thus it appears improbable that certain antibody 
fragments even if they bind across the species barrier, will have general protective effects against 
coccidia. 
None of the tested antibody fragments showed positive binding reaction with merozoites. This 
property will be a disadvantage because sporozoites invading host cells in spite of presence of 
antibody fragments will induce rapid multiplication of the parasite and eventually oocyst 
excretion. A single oocyst, single sporocyst or single sporozoite is able to give rise to a clonal 
population of the respective Eimeria species (SHIRLEY and HARVEY 1996). To produce 
effective recombinant antibodies against multi-stage protozoan parasites such as Eimeria spp. it 
would be advantageous if they would target antigens of different stages. This would include 
sporozoite antigen to protect against the first invasive stages and merozoite antigen to prevent 
asexual multiplication which might appear if sporozoites escape the first line of defence. 
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To investigate the most suitable cell culture line to be used for the invasion inhibition assay, 
some preliminary trials on different cell lines were performed. Madin-Darby Bovine Kidney 
cells (MDBK) appeared most suitable and were chosen for the in vitro model to investigate and 
evaluate sporozoite invasion in accordance to previous reports (DORAN and VETTERLI 1967; 
BUMSTEAD et al. 1998; TIERNEY and MULCAHY 2003; TIERNEY et al. 2004; JOHNSON 
et al. 2004; ALLEN 2007).  
During the course of this study particular attention was paid to the effect of antibody fragments 
on the sporozoite invasion rate. Initially only microscopical examination was available which is 
rather qualitative than quantitative in terms of invasion inhibition rates. Labeling with 
radioactive isotopes would be a good alternative but was not applicable under the given 
conditions. Flow cytometry appeared suitable to assess the invasion inhibition rates precisely 
using labeling with vital fluorescence stain (RAETHER et al. 1991; HOFMANN et al. 1993) and 
recently CFSE labeling was used (LABBE et al. 2005; HERMOSILLA et al. 2008). In the 
present study CFSE-labelling was applied as it is time saving and easy to perform in comparison 
to antibody-based immunoassays which require specific antibodies, fixation and other 
procedures to support binding of the antibodies to parasitic antigens. CFSE has successfully been 
used to investigate drug effects against parasites, e. g. assessment of proliferation of CFSE-
stained Leishmania infantum promastigotes after exposure to allopurinol (KAMAU et al. 2000) 
and to dinitroaniline compounds by flow cytometry analysis (KAMAU et al. 2001), indicating 
the applicability of CFSE in pharmacological screenings. CFSE also has been used to label E. 
bovis sporozoites and meronts to study parasite-host cell interactions in vitro (HERMOSILLA et 
al. 2008) and to investigate functions of ETMIC3 (E. tenella microneme protein 3) and its 
importance during host cell invasion by E. tenella sporozoites (LABBE et al. 2005).  
Invasion rates were clearly reduced in host cells incubated with sporozoites treated with antibody 
fragments, however, proliferation rates of the host cells were also affected under these 
treatments. This suggested the presence of some toxic compounds in the tested antibody 
preparations which may induce detrimental effects on the viability and proliferation of the cell 
culture. To assess this assumption sera from non-infected chicken and chicken infected with 
Eimeria tenella or polyclonal antibody developed against EbCDPK were applied. It was noticed 
that sera, either heat inactivated or non-heated, did not negatively affect the PR of MDBK cells 
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but instead increase PR, especially if heat inactivated. The latter may reflect removal of 
complement from the serum by heat inactivation whereas general increase of PR is probably due 
to other constituents and nutrients in the sera such as essential amino acids. 
In the antibody neutralization assay, the sample size was small (9 chicken in each group). 
However, for scoring of pathological lesions groups of around 10 are rather common 
(HORTON-SMITH and LONG 1963; HORTON-SMITH and LONG 1966; CRANE et al. 1986). 
It was not possible to repeat this experiment because of limited availability of antibody 
fragments. More in vivo studies on a larger scale are needed to get a data quality sufficient for 
statistical analysis. The intracecal inoculation technique used in the in vivo antibody 
neutralization assay appeared suitable to estimate sporozoite infectivity and may be applied in 
further studies related to detection and quantification of antibody effects on sporozoite activity in 
vivo. 
The artificial excystation performed for both in vitro and in vivo assays may have led to the loss 
of some membrane protein, i.e. antigens (WISHER and ROSE 1987), possibly due to proteolysis 
by trypsin present in the excystation medium (TOMLEY 1994). Both assays should be similarly 
biased by this, however, oocyst excretion was more reduced after sporozoite incubation with 
antibody fragments (especially Ab1, Ab3, Ab5, and Ab9) than expected from the result of the in 
vitro inhibition assay. To fully understand the potential of antibody fragment application for the 
control of coccidiosis co-factors must be taken in consideration such as the intestinal barrier, 
quality and amount of intestinal content, and the immune response including the local 
inflammatory reaction. Increased intestinal permeability, resulting in plasma leakage from 
vasculature, may coincide with cell invasion (CASTRO 1989). GALT (gut associated lymphoid 
tissue) and MALT (mucosal-associated lymphoid tissue) play important roles by processing and 
presentation of antigens, production of intestinal antibodies (primarily secretory IgA), and 
activation of cell mediated immunity (YUN et al. 2000b; DALLOUL and LILLEHOJ 2005). 
These different elements could contribute to the more or less distinct inhibitory effect of the 
tested antibody fragments in vivo, however, this remains to be characterized in future studies. 
Whatsoever, the sporozoites are obviously facing more hindrance under in vivo conditions to 
invade the epithelial cells of the host than assumed from in vitro studies. 
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Conclusion 
In this study, a simple method was established for single oocyst infection which can be used to 
produce pure strains from field samples. However, maintenance of purity was not successful 
under the given conditions, although contamination remained on an acceptable level. 
All tested antibody fragments showed moderate inhibitory effect on the invasion rates of the 
sporozoites in vitro. 
Some of the tested antibody fragments (Ab1, Ab3, Ab5 and Ab9) were more capable to 
neutralize E. tenella sporozoites infectivity in vivo than others (Ab2, Ab4, Ab6, Ab7 and Ab8). 
In vitro invasion inhibition can be combined with assessment of E. tenella sporozoite infectivity 
in vivo after intracloacal inoculation to produce quantitative inactivation data. 
Flow cytometry is a suitable quantitative assay for assessment of the sporozoite invasion in vitro. 
Further studies are necessary to elaborate the potential efficacy of antibody fragment application 
to chicken exposed to coccidiosis and if unequivocally demonstrated, to optimise their 
application and dosage. 
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Die Hühnerkokzidiose verursacht weltweit erhebliche wirtschaftliche Verluste. Aufgrund der 
zunehmenden Resistenzen der Eimeria-Arten gegen die häufig eingesetzten Antikokzidia besteht 
ein großes Interesse an alternativen Methoden zur Kontrolle der Kokzidiose beim Geflügel. Die 
vorliegende Studie untersucht die potentiell inhibitorische Wirkung von Anti-Eimeria-tenella-
Antikörperfragmenten aus Erbsen. Hierzu wurden die indirekte Immunfluoreszenz, ein 
Infektionsassay nach In-vivo-Antikörper-Neutralisation und ein Zellkultur-Invasionshemmtest 
eingesetzt. 
Sieben von neun Antikörperfragmenten (Ab1, Ab4, Ab5, Ab6, Ab7, Ab8 und Ab9) zeigten im 
indirekten Immunfluoreszenztest eine Bindung an Sporozoiten von E. tenella. Nur zwei 
Antikörper-Fragmente (Ab4 und Ab5) zeigten Kreuzreaktivität mit Sporozoiten von E. maxima, 
E. brunetti und E. acervulina, die Lokalisation der spezifischen Fluoreszenz unterschied sich 
jedoch zwischen den Arten. Eine Markierung mit Ab4 und Ab5 wurde an den vorderen und 
hinteren Refraktilkörperchen im Fall der Sporozoiten von E. tenella, E. brunetti, und E. maxima 
aber nur am hinteren Refraktilkörperchen im Falle von E. acervulina gesehen. Eine Bindung an 
Merozoiten wurde bei keiner der getesteten Eimeria-Arten beobachtet. 
Die Eignung der Antikörper, die Infektiosität von E. tenella für bovine Nierenzellen (MDBK) zu 
verändern, wurde in vitro im Invasionshemmtest mittels Durchflusszytometrie quantifiziert. Um 
die inhibitorische Wirkung dieser Antikörperfragmente auf die Reproduktion der Parasiten im 
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natürlichen Wirt zu beurteilen, wurde der In vivo-Antikörper-Neutralisationstest durchgeführt. 
Dabei infezierte man die Hühnerküken retrograde mit Sporozoiten, die vorher In vitro mit 
Antikörperfragmenten inkubiert wurden 
In den Zellen, die mit Antigenfragment-behandelten Sporozoiten infiziert wurden, waren die In-
vitro-Invasionsraten  um zirka 24 bis 45 % reduziert, wobei Ab6 und Ab7 den deutlichsten 
Effekt zeigten. Allerdings wurden auch die Proliferationsraten (PR) der MDBK-Zellen um 15 bis 
26 % vermindert. Im Verhältnis 1:1000, 1:100 oder 1:10 verdünnte oder unverdünnte 
Antikörperfragment-Präparationen reduzierten die PR um 1 %, 10 %, 16 % oder 26 %, während 
die entsprechenden Infektionsraten um 0 %, 9 %, 15 % oder 18 % sanken. Serum infizierter 
Tiere reduzierte die Invasion um 16 bis 70 % und förderte zudem die Proliferation der 
Wirtzellen. 
Es scheint, dass die Antikörperfragment-Zubereitungen Komponenten enthielten, die einen 
zytotoxischen Effekt auf die MDBK-Zellen hatten. Aus diesem Grund konnte die 
Invasionshemmung in vitro nicht eindeutig beurteilt werden. Eine weitere Analyse dieser 
Beobachtung war aufgrund der begrenzten Mengen an Ab-Präparationen nicht möglich.  
Nach der Inkubation mit Antikörperfragmenten zeigten Sporozoiten eine reduzierte Fähigkeit 
sich nach einer intrakloakalen Infektion in Hühnern zu reproduzieren (insbesondere Fragmente 
Ab1, Ab3, Ab5 und Ab9). Andere Antikörperfragmente (Ab2, Ab4, Ab6, Ab7 und Ab8) waren 
weniger geeignet, die Infektion durch Sporozoiten und damit die Reproduktion zu verringern. 
Weitere Untersuchungen sind erforderlich, um den möglichen Nutzen der Antigenfragmente aus 
Erbsen zur Bekämpfung der Hühner-Kokzidiose abzuschätzen und ihre Wirkung auf infizierte 
Hühner zu testen. 
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Coccidiosis in chicken causes great economic losses. Increasing resistance of Eimeria species to 
anticoccidials has forced the search for alternative methods of control. 
The present study evaluates the anticoccidial activity of some anti-Eimeria tenella antibody 
fragments expressed in pea plants. Both in vitro and in vivo infection assays including indirect 
immunofluorescence, in vivo evaluation of antibody neutralization and cell culture invasion-
inhibition assays were used to study the inhibitory effect of these antibody fragments on E. 
tenella sporozoites. 
Seven of nine antibody fragments (Ab1, Ab4, Ab5, Ab6, Ab7, Ab8 and Ab9) showed binding to 
sporozoites of E. tenella in an indirect immunofluorescence test. Only two antibodies (Ab4 and 
Ab5) cross reacted with sporozoites of E. maxima, E. acervulina and E. brunetti. The 
localization of specific fluorescence differed between species. Ab binding with sporozoites was 
seen in the area of both anterior and posterior refractile bodies in case of E. tenella, E. brunetti, 
and E. maxima but was only observed in the posterior refractile body in case of E. acervulina. 
No antibody binding was observed on merozoites. 
The suitability of antibody fragments to alter the infectivity of E. tenella sporozoites to Madin 
Darby Bovine Kidney cells (MDBK) was examined in vitro and the invasion-inhibition rates 
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were quantified by flow cytometry. To assess the inhibitory effect on parasite reproduction, the 
in vivo antibody neutralization assay was done by retrograde infection of chicken with 
sporozoites previously incubated with antibody fragments. 
In vitro invasion rates were reduced by incubation with antibody fragments by approximately 24 
to 45 %, with Ab6 and Ab7 showing the most distinct effect. However, proliferation rates (PR) 
of the respective MDBK cultures were also clearly reduced by 15 to 26 %. 
PR of MDBK cells treated with 1:1000, 1:100, 1:10 and undiluted mixed antibody fragments 
were reduced by 1%, 10%, 16%, and 26% with a reduction of invasion rates by 0%, 9%, 15% 
and 18%, respectively. Immune sera reduced the invasion rates by 16% to 70% and increased PR 
of the host cells. 
It appeared that the preparations of the antibody fragments contained compounds cytotoxic to 
MDBK cells and thus invasion inhibition could not be unequivocally evaluated in vitro. 
However, after incubation with antibody fragments sporozoites displayed a reduced ability to 
reproduce after intracloacal application to chicken (especially Ab1, Ab3, Ab5 and Ab9). Other 
antibody fragments (Ab2, Ab4, Ab6, Ab7 and Ab8) were less capable to reduce sporozoite 
infectivity and reproduction. 
More investigations are still required to study the possible use of antibody fragments and their 
application to infected chicken exposed to coccidiosis. 
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